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SUMMARY 
 
 
The Gadd45 family proteins play a central role as stress sensors that modulate the 
response of mammalian cells to stress inflicted by physiological and environmental 
factors. Gadd45a and Gadd45b behave either as oncogenes or as tumor suppressor genes 
in a cell-type dependent manner. Despite their role has been extensively studied in 
various cancers, the functions played by these proteins in hepatocellular carcinoma 
development remains unknown. We addressed this issue by studying HCC development 
in a cohort of wild-types Gadd45a and Gadd45b null mice injected with 
diethylnitrosamine (DEN) a hepatocarcinogenic agent. We show that loss of either 
Gadd45a or Gadd45b strongly inhibits DEN-induced hepatocarcinogenesis. The lack of 
Gadd45b or Gadd45a in mice decreased hepatocyte death and compensatory proliferation, 
after DEN treatment. IL-6 is required for proliferation upon DEN-injection and the 
decrease of IL-6 production in both Gadd45a and Gadd45b null mice was linked to a 
decrease in JNK activation. Furthermore, we show that ablation of Gadd45b in Kupffer 
cells, but not in hepatocytes, is sufficient to recapitulate the decrease in proliferation and 
IL-6 production observed in whole body Gadd45b null mice. Altogether, these results 
provide a novel role for both Gadd45b and Gadd45a as oncogenes during DEN-induced 
HCC, and establish Gadd45b as critical player in regulating IL-6 production during liver 
injury.  
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RESUMEN 
 
 
La familia de proteinas GADD45 tiene un papel central como sensor de estrés, 
modulando la respuesta de las células de mamíferos frente a los estímulos fisiológicos y 
ambientales. Tanto Gadd45a como Gaad45b, pueden comportarse como oncogenes o 
genes supresores tumorales dependiendo del tipo celular en el que actúen. Su papel se ha 
estudiado ampliamente en varios tipos de cáncer, sin embargo la función que llevan a 
cabo dichas proteínas en el desarrollo del carcinoma hepatocelular continúa siendo 
desconocida.  Nosotros abordamos este tema empleando una cohorte de ratones WT y 
deficientes en Gadd45a y Gadd45b, inyectados con DEN, un agente hepatocarcinógeno.  
En este estudio se muestra cómo la pérdida tanto de Gadd45a como de Gadd45b inhibe 
fuertemente el desarrollo del hepatocarcinoma inducido por la inyección de DEN. La 
ausencia de Gadd45a o Gadd45b disminuye la muerte  de hepatocitos y la consiguiente 
proliferación compensatoria, inducida por la DEN. La IL-6 es esencial para el proceso de 
proliferación en el modelo de la DEN. La disminución de la producción de IL-6 en 
ratones deficientes en Gadd45a o Gadd45b se ha asociado a una menor activación de 
JNK. Además, mostramos cómo la falta de Gadd45b en las células de Kupffer, pero no en 
hepatocitos, es suficiente para provocar esa disminución en la  producción de IL-6 y en la 
proliferación compensatoria, que podíamos observar en los ratones Gadd45b knockout.  
Con todo ello, estos resultados proveen un nuevo papel para Gadd45a y Gadd45b como 
oncogenes durante el desarrollo del hepatocarcinoma inducido por DEN y establecen a 
Gadd45b como un regulador clave en la producción de IL-6 durante el daño hepático 
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1.	Liver:	anatomy	and	functions	
 
Extending across the entire abdominal cavity, the liver is a roughly triangular organ 
weighting approximately 1.5 kilograms. It consists of four lobes, the left and the right, 
located on the frontal side, and the quadrate and the caudate, located on the posterior side. 
The gallbladder, a small organ whose main purpose is to store bile, is located just beneath 
the right lobe (Fig I-1). 
Blood is delivered to the liver by the hepatic portal vein, where it divides into the liver’s 
complex system of arteries and arterioles that provides cells with all the required 
nutrients (Fig. I-2). The hepatic arteries then converge into the hepatic vena cava, which 
brings the blood to the heart.  
The liver is anatomically divided into hexagonal functional units called lobules. At the 
center of the hexagonal structures lies the central vein, whereas at each of the 6 corners 
lie 6 hepatic portal veins coupled to 6 hepatic arteries, these blood vessels are connected 
by capillary-like tubes called sinusoids. At the center of the hexagon, traversed by the 
sinusoids, lie the liver cells.  
The liver is a paramount and vital organ performing essential functions for the body 
homeostasis. Among the numerous functions (around 500 to date) (Zakim, 2002) 
described are:  storage of sugar and glucose to provide vital energy for the body, storage 
of essential vitamins and iron, blood detoxification from harmful substances, red blood 
cells elimination, metabolization of thousands of xenobiotics and the production of bile, a 
compound aiding digestive processes by emulsifying lipids. Furthermore, the liver is 
responsible for the breakdown of hormones like insulin, and the breakdown of bilirubin, 
facilitating its excretion into bile. The liver possess the remarkable ability of 
regeneration: even if 3/4 of the liver are removed, the remaining liver cells exit 
quiescence and initiate proliferative processes aimed at restoring the original liver mass. 
It is important to notice that in mammals, the lobes that are removed are unable to regrow, 
and the restoration of the mass is the result of proliferation of the lobes not being 
removed.  
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Figure I-1.  Illustration of a human liver and its position in the body. (Copyright © 2008 
WebMd LLC)  
                                                    
                                  
Figure I-2. Representation of the structure of a hepatic lobule (Copyright © 2011 
Pearson Education) 
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1.	The	three	types	of	liver	cells 
      
The liver consists of three cell populations: hepatocytes, Kupffer cells and stellate cells, 
illustrated in Figure I-3                  
                               
Figure I-3. Representation of the various cellular types present in the liver: Hepatocytes, 
Kupffer cells and Stellate cells (Tsutsui & Nishiguchi, 2014) 
 
                        
1.1	Liver	hepatocytes	
 
By constituting around 70% of the liver, the hepatocytes are the main cell type associated 
with liver-specific functions. They are round, cubical cells, typically 20-30 µm of 
diameter. Tetraploidy or polyploidy represent common features in hepatocytes nuclei. 
Hepatocytes metabolize exogenous compounds and are the main sites of synthesis for 
transferrin complement and glycoprotein (Zakim, 2002). They can perform 
gluconeogenetic processes and the formation of triglycerides and fatty acids from 
carbohydrate. 
In normal conditions, they are quiescent cells, but can be primed to reenter cell cycle 
following liver injury. Their central role in xenobiotic metabolism and the numerous 
functions performed renders this cell type prone to injury. Hepatocyte injury can result in 
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hepatocyte death via apoptosis or necrosis.  Apoptosis contributes to liver homeostasis by 
removing damaged cells, however, deregulation of such process are common to many 
liver pathologies (Malhi et al, 2010; Yagmur et al, 2007).. Enhanced hepatocyte apoptosis 
is tightly coupled with inflammation and fibrosis (Hikita et al, 2009; Takehara et al, 
2004) and increase in hepatocyte apoptosis stimulates proliferation of nearby hepatocytes, 
a process essential for cancer development. Apoptosis is commonly initiated and 
executed by activation of intracellular protease enzymes called caspases. Apoptosis can 
be initiated either in an extrinsic or intrinsic manner. In the former, caspases are activated 
by binding of cell membrane death receptor activation to their extracellular ligands, such 
tumor necrosis factor alpha (TNF-α), transforming growth factor beta   (TGF-β), and 
(TRAIL). In the latter, cellular stress enhanced mitochondrial membrane permeability, 
allowing Cytochrome C release into the cytosol, which triggers caspase activation.  In the 
liver, crosstalk among hepatocytes and Kupffer cells is crucial in mediating responses to 
stress. 
Hepatocyte proliferation for instance, constitutes the fundamental driving process of liver 
regrowth in response to chronic or acute liver injury causing hepatocyte death (Fausto, 
2005). The initiation of this response involves the production of priming factor such as 
interleukin 6 (IL-6), secreted by Kupffer cells. These priming factors are thought to prime 
hepatocyte to respond to growth factors such as hepatocyte growth factor (HGF) and 
epidermal growth factor (EGF), which stimulate hepatocyte to reenter cell cycle 
(Zimmermann et al, 2005).  
 
1.2	Kupffer	cells	
 
Kupffer cells are resident liver macrophages making around 30%? of the total liver cells 
(Bilzer et al, 2006). They reside in the sinusoids and derive from bone marrow monocytes 
that upon migration establish into the liver becoming its resident macrophages. The most 
important activators of this cell group are the complement factors C3a and C5a, β-
glucans and lipopolysaccharide from bacteria, (Bilzer et al, 2006).  Once activated, they 
can secrete a vast array of cytokines mediating responses to stress. Kupffer cells 
participate in processes such as host defense, by clearing bacteria from the blood stream; 
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indeed, they constitute the first macrophage population that comes in contact with 
bacteria and endotoxins deriving from the gastrointestinal tract. They are essential for the 
optimal liver regenerative ability by producing TNF-α (Yamada et al, 1997) and IL-
6 (Cressman et al, 1996), can promote alcoholic liver injury and contribute to the 
pathogenesis of non-alcoholic fatty liver disease (Adachi, 1994). In response to liver 
stress such as p, such as DEN injection or partial hepatectomy (PH), Kupffer cells secrete 
factors, such as IL-6 and TNF-α, which are required for hepatocyte to reenter cell cycle, 
enabling correct liver regeneration (Prins et al, 2005). Once released, these cytokine 
trigger liver regeneration mainly by stimulating the nuclear Factor κB (NF-κB) and signal	 transducer	 and	 activator	 of	 transcription	 3 (STAT3) pathway. Liver 
regeneration is indeed compromised in mice depleted of Kupffer cells due to lower 
expression of TNF-α (Murata et al, 2008). Diethylnitrosamine (DEN) and acute liver 
failure are two characterized stress responses involving a Kupffer cell dependent 
regeneration. During DEN acute liver injury for instance, necrotic hepatocytes release IL-
1α, which in turn stimulates Kupffer cells to produce IL-6, a paramount cytokine 
promoting hepatocyte division and liver regeneration. Taking advantage of their origin 
from bone marrow, Kupffer cells genes function can be studied thanks to bone marrow 
transplant, by lethally irradiating mice and transplant the bone marrow deficient in the 
gene of interest.  Kupffer cells have indeed a lifespan of around 40 days and, following 
bone marrow transplantation, can repopulate the liver in a period comprised between 14 
to 21 days (Naito et al, 1991). 
1.3	Stellate	cells:		
  
They are perycites located in the area between the sinusoid and the hepatocytes, called 
the Disse space. Representing roughly 5% of the liver’s total number of cells 
(Hellerbrand et al, 2013), and in normal conditions are thought to be quiescent. 
Activation occurs in response to liver stress and to collagen production that can 
eventually contribute to liver fibrosis.   
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 2	Hepatocellular	Carcinoma 
 
2.1	The	biology	of	HCC	
 
Hepatocellular Carcinoma (HCC) is the primary malignancy of the liver, accounts for 
75% of primary liver cancers and is the third leading cause of cancer death. The survival 
rate is around 50% and chronic liver injuries such as the ones caused by hepatitis B, 
hepatitis C, cirrhosis and excessive alcohol consumption can enhance the probability of 
onset of this disease. HCC has a higher incidence in males than in females, probably 
because of hormonal reasons, and is most common between the ages of 30 and 50 (Forner 
et al, 2012). This cancer is most common in Asia, where 5 to 10% of the population is 
infected by hepatitis B (Alavian & Haghbin, 2016). Nowadays, vaccination against 
hepatitis B, limiting alcohol consumption and having a healthy diet represent the best 
form of prevention, especially for patients having a familiar history of HCC. HCC can be 
either poorly differentiated, with giant and anaplastic cells, or differentiated, where cells 
resemble hepatocytes. Different techniques are used for the diagnosis of this cancer: 
ultrasound is used mainly for screening, whereas CT scan or an MRI is more appropriate 
in people with a high suspicion of liver cancer. The liver image reporting and data system 
(LI-RADS) is the system of HCC classification based on CT scan: LR1 and LR2 are the 
less severe diagnosis, indicating that the tumor is benign or probably benign respectively. 
LR3 LR4 LR5 are the more severe diagnosis, indicating a non-benign tumor and LR5 
being the more severe grade. Criteria such as size, tumor vascularity, involvement of liver 
vessels and presence of extrahepatic metastases are crucial factor in determining 
treatment approach. Various therapies are available for HCC treatment, both surgical and 
non-surgical. The surgical approaches consist of liver transplant or tumor resection, the 
former being extremely dependent on patient selection whereas the latter presents a 50 to 
60% recurrence rate and only 10 to 20% of liver tumors can be removed surgically. The 
non-surgical approaches involve radiotherapy and chemotherapy. The sole agent 
approved by the FDA to treat HCC is sorafenib, a receptor tyrosine kinase inhibitor, 
which inhibits tumor proliferation and angiogenesis and enhances apoptosis in tumor 
cells (Abdel-Rahman et al, 2014). 
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Given the low survival rate of HCC after the diagnosis, is essential to understand the 
molecular pathways and genetic alterations leading to HCC development. An 
understanding of these phenomenon can contribute to identify new therapeutic targets 
and novel strategies for HCC treatment. 
In regard to genetic alterations, amplification of the chromosomes 1q, 8q. 6p, and 17q 
and the loss of chromosomes 8p, 16q, 4q, 17p, and 13q were found to be among the most 
prominent (Moinzadeh et al, 2005). As for molecular pathways, many were found to have 
crucial roles in HCC development.  More than 200 codons mutations affect the p53 gene 
in HCC. 62% of HCC were shown to display β-catenin deregulation (Inagawa et al, 
2002). These mutations prevent β-catenin from being phosphorylated, causing an 
overactivation of Wnt β-catenin pathway (Willert et al, 2002). Overexpression of TGF-β 
is commonly found in HCC (Abou-Shady et al, 1999).TGF-β  displays a growth limiting 
function in many cellular contexts and the reason of its expression in HCC is not fully 
understood. A resistance of tumors to TGF-β signal or a switch of TGF-β  to a tumor 
promotive role are reasonable hypothesis explaining this phenomenon. Various studies 
have shown an upregulation of Ras and a downregulation of Ras inhibitors in HCC 
(Nomura et al,1987; Schuierer et al, 2006). N-Ras, H-Ras and K-Ras, the three genes 
belonging to the Ras family group, display common mutation in the codon 61, 12 and 12 
respectively (Takada et al, 1989; Challen et al, 1992; Cerutti et al, 1994). The Raf-1 
essential target mediated many of the Ras associated function, is inhibited by sorafenib 
(Abou-Alfa et al, 2006). The Retinoblastomas suppressor protein (Rb) has also been 
implicated in HCC development. In human HCC cell lines and in 28% of HCCs this 
protein is inactivated (Suh et al, 2000; Azechi et al, 2001). Moreover, other members of 
the Rb network display altered expression in HCC. Cyclin D1/CDK4 complex is 
overexpressed in 58% of HCCs and p16, a Cyclin-dependent kinase 4 (CDK4) inhibitor 
is absent in 34% of HCCs (Joo et al, 2001; Liew et al, 1999). 
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2.2	HCC:	The	DEN	model	
 
Numerous mouse models, either genetic or chemically induced, have been developed in 
the past decades in order to study HCC patterns. The important question is to assess the 
extent to which these models mimic human HCC. Genetic profiles of mouse tumors 
induced by DEN, an alkylating agent, share many similarities to expression profiles of 
HCC with poor prognosis (Lee et al, 2004). Furthermore, mutations in the H-Ras 
protooncogene, associated with poor prognosis in humans, are commonly found in DEN 
induced tumors (Stahl et al, 2005). Upon intraperitoneal injection (IP) DEN is 
hydroxylated in the liver by cytochrome p450 to alpha-hydroxylnitrosamine. This 
compound causes DNA damage by reacting with DNA bases  (Verna et al, 1996). 
Reactive oxygen species (ROS) generated by cytochrome p450 might also contribute to 
DEN tumorigenic potential (Valko et al, 2006). The liver possess the remarkable capacity 
to restore its original mass upon stress, starting 24 hours after DEN injection, a fraction 
of the liver cells undergoes DNA damage induced apoptosis. Neighboring cells exit the 
quiescent state and divide in order to restore the original cell number. This process is 
essential to produce the DEN-driven genetic mutations eventually leading to 
carcinogenesis, as DNA adducts formed by DEN only result in mutations upon DNA 
duplication (Fig. I-3). Therefore, defects in the apoptotic pathways or in pathways 
enabling cellular proliferation can significantly affect DEN-induced tumorigenesis. 
Puma-null mice for instance, a protein involved in the apoptotic pathway, are resistant to 
DEN-induced tumorigenesis due to their intrinsic inability to undergo apoptosis (Qiu et al, 
2011). Cytokine-mediated crosstalk between hepatocytes and Kupffer cells is crucial for 
DEN-induced tumor development. Following DEN injection necrotic hepatocytes release 
IL-1α in the extracellular milieu (Sakurai et al, 2006), which activates Kupffer cells to 
secrete IL-6, which in turn primes hepatocytes to enter cell cycle (Fig. I-4) (Zimmers et al, 
2003). Various factors such as genetic strain, age and sex of the mice contribute to the 
efficiency of the DEN tumorigenic processes. Males are more susceptible than females to 
HCC development. These differences in susceptibility are due to the inhibitory effects of 
estrogens and the positive effects of androgens on HCC development (Nakatani et al, 
2001). A single IP injection of DEN is not sufficient to produce HCC in two weeks old 
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mice but not in adult mice (Shiota et al, 1999).  
DEN is also used as the initiator agent in a two-stage model. After DEN injection mice 
are treated with phenobarbital (PB), which by increasing cytochrome p450 expression, 
oxidative stress, methylating promoter regions of tumor suppressor genes, exponentially 
enhances DEN carcinogenic potential. (Waxman & Azaroff, 1992; Imaoka et al, 2004; 
Watson & Goodman, 2002). Tumors induced by DEN in conjunction with PB display 
mutations in the β-catenin gene (Aydinlik et al, 2001). When 6 to 10 week old mice are 
injected with DEN followed by PB, the compound enhances DEN tumorigenesis. 
Biochemical differences between adult and infant hepatocytes might account for this 
phenomenon. Promotion of tumors with PB is also dependent on gender and strain 
differences (Weghorst & Klaunig, 1999; Goldsworthy et al, 2002). In infant mice 
however, DEN induces tumors in absence of PB. Indeed, when 15 days old mice are 
injected with a DEN dose of 25 mg/kg tumors will develop in PB-independent manner 
with an average latency of 40-weeks (Bakiri et al, 2013). This is the approach we used to 
induce tumors in our mice. 
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Figure I-4.  Representation of the initial steps involved in DEN-induced carcinogenesis. 
(Adapted from Allan and Travis, 2005).  
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Figure I-5: Crosstalk among Kupffer cells and hepatocytes after DEN injection.: 
Necrotic hepatocytes release IL-1α in the extracellular milieu, which activates Kupffer 
cells to produce IL-6. IL-6 stimulates hepatocytes with damaged DNA to enter cell cycle, 
thus favoring DNA mutations.   
 
3		The	Gadd45	family	proteins.		
 
3.1	The	Gadd45	family	members	
 
Growth arrest and DNA damage inducible  (Gadd45) gene family consists of three 
members, Gadd45a, Gadd45b and Gadd45g, having key roles in the integration of 
various intra and extracellular stimuli with their appropriate cellular responses 
(Liebermann and Hoffman, 2003). Gadd45 proteins are very acidic, weigh around 18 kD 
and share 55 to 57% of homology with each other (Abdollahi et al, 1991).  They are 
expressed in various tissues, such as liver, brain, kidneys, muscles and testis (Zhang et al, 
1999). The coding genes are located on chromosome 1, 19 and 9 for Gadd45a, Gadd45b 
and Gadd45g respectively. Despite the high degree of sequence homology they can differ 
substantially in their regulation and function (Lieberman and Hoffman, 2003). These 
differences can be attributed to both the different spectrum of binding factors of each 
family member and different regulation of expression. For instance, only Gadd45a 
contains binding motifs for p53 and activator protein 1 (AP1) in its genetic region (Jin et 
al, 2001; Daino et al, 2006). To date, no enzymatic activity in each one of the 3 family 
members has been identified, as a result, these proteins are believed to exert most of their 
cellular functions via protein-protein interaction. Besides interaction with a wide plethora 
of proteins, Gadd45 family members can form homodimers and heterodimers with other 
Gadd45 family proteins as well as oligomers (Kobayashi et al, 2005; Schrag et al, 2008). 
In basal conditions their expression is very low, but it can raise substantially when cells 
are subject to both intra and extracellular stresses (Moskalev et al, 2012).  
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3.2	Gadd45	in	apoptosis	and	cellular	proliferation		
Gadd45 proteins are generally known to promote apoptosis in a variety of cell type and 
contexts. Ectopic expression of Gadd45 proteins triggers apoptosis in mouse hepatocytes 
in a p38 and c-Jun N-terminal kinases (JNK) dependent manner and Gadd45b-null 
hepatocytes are resistant to TGF-β-mediated apoptosis (Selvakumaran et al, 1994; Yoo et 
al, 2003).  
To note, Gadd45a also inhibits apoptosis in some contexts, for instance it protects 
melanoma cell from cell death in response to cisplatin and UV radiation (Smith et al, 
1996). Gadd45a expression in pancreatic cancer is associated with reduced prognosis and 
apoptosis resistance (Hildesheim et al, 2002). Studies on Gadd45b gene also highlight a 
proapoptotic role in many contexts. Indeed Gadd45b overexpression induces apoptosis in 
HeLa cells and mediates the apoptotic response to neural ischemia (Cretu et al, 2009). In 
vitro, ectopic expression of Gadd45 members blocks cell growth by arresting cells in the 
G2/M phase or by induction of apoptosis in several human cell lines such as H1299 lung 
carcinoma, HeLa cervical cancer cells and NIH3T3 embryonic fibroblasts (Moskalev et 
al, 2012). Gadd45b overexpression however, protects B-cells from activation-induced 
cell death, indicating that this protein, like Gadd45a, exerts an antiapoptotic role in some 
context (Schmitz et al, 2013). 
 
Induction of Gadd45a is generally suppressed by growth regulatory stimuli, indicating 
that in many instances this protein antagonizes cellular proliferation. Loss of Gadd45a is 
sufficient to transform cells with H-ras gene (Bulavin et al, 2003). Expression of 
Gadd45b is negatively regulated by protooncogenes such as c-Myc and AKT virus 
oncogene cellular homolog (AKT), further confirming its role in growth suppression. In 
vivo lack of Gadd45b can have context-specific effect on cellular proliferation. While 
lack of Gadd45b impairs regeneration after partial hepatecomty (Papa et al, 2008), it can 
cause a modest increase in proliferation in liver hyperplasya induced by 1,4-bis[2-(3,5-
dichloropyridyloxy)]benzene  (TCPOBOP) treatment (Tian et al, 2011).  
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3.3	Gadd45	proteins	in	cancer	
 
Gadd45 proteins have been mainly associated with tumor suppressive properties in 
various tumor types. Gadd45a-/- mice show genomic instability, increased sensitivity to 
carcinogenesis and are more prone to 7,12-Dimethylbenzantrancene (DMBA) induced 
ovarian tumors (Hollander et al, 1999; Hollander et al, 2001). Furthermore, Gadd45a 
inhibits the onset of mammary tumors by inducing JNK and p38 mediated apoptosis and 
senescence respectively (Tront et al, 2010). Also, disruption of Gadd45a expression was 
found in many hematopoietic malignancies (Qiu et al, 2003; Sun et al, 2003; Ying et al, 
2005). Gadd45b-/- mice are more susceptible to ionizing radiation, chemical carcinogens, 
and display an impaired immune response to implanted melanoma cells (Ju et al, 2009). 
In vitro, ectopic expression of Gadd45 proteins block cell growth by arresting cells in the 
G2/M phase or by induction of apoptosis in several human cell lines such as H1299 lung 
carcinoma, HeLa cervical cancer cells and NIH3T3 embryonic fibroblasts. (Zhan et al, 
1994; Zhang et al, 2001; Sun et al, 2003). The ability of Gadd45 family members to 
induce apoptosis in various cancer cell lines is crucial for various pharmacological agents, 
for instance Gadd45a expression is required in MCF7 human breast carcinoma cells for 
Troglitazone-induced apoptosis (Yin et al, 2004). Besides suppressing cancer 
development by inducing apoptosis, Gadd45 proteins can also suppress cancer by 
inhibiting cellular migration, for instance silencing of Gadd45a expression by shRNA 
inhibits the migration of BL185 murine cell line and HCC cell lines (Trabucco et al, 
2010). 
Methylation appears to be a way through which Gadd45 proteins expression is silenced. 
In liver cancers, for instance the promoter of Gadd45b is methylated in HCC (Qiu et al, 
2004). As for Gadd45a, at least in the case of breast cancer, point mutations seem to be 
the likely mechanism of its inactivation (Campomenosi et al, 2000). 
In many, but not all, instances therefore, Gadd45 proteins display tumor suppressive 
functions. Various are indeed the drugs whose chemotherapeutic effect is dependent on 
Gadd45 proteins. Gadd45a is induced by CD437, Genistein, Trichostatin A and 
Nonsteroidal anti-inflammatory drugs (NSAID), all drugs used for chemotherapeutic 
purposes (Oki et al, 2004; Zerbini et al, 2005; Campanero et al, 2008), and Gadd45b is  
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required for sorafenib-induced apoptosis in hepatocellular carcinoma cells (Ou et al, 
2010) 
Despite a great number of evidences indicating Gadd45 proteins are relevant in tumor 
suppressive function, in some cases these proteins might exert a paradoxical opposite 
action. For instance, while Gadd45a suppresses Ras driven breast tumorigenesis, it 
enhances tumorigenesis when breast tumors are induced through Myc overexpression. 
Thus, Gadd45a plays either a tumor promotive or suppressive role in an oncogene 
dependent fashion (Tront et al, 2010). Ablation of Gadd45a in Myc driven mammary 
tumorigenesis results in either apoptosis or cellular senescence. 
 
3-4	Gadd45	proteins	in	liver		
 
Gadd45b expression is rapidly increased in response to many liver challenges, such as 
PH, hyperplasia, and response to xenobiotic. This increase is essential to maintain liver 
homeostasis. In particular, several evidences suggest a key role for Gadd45b in mediating 
hepatocyte proliferation.  
Gadd45b-/- mice are unable to regenerate the liver after PH (Papa et al, 2008), a surgical 
procedure where 3/4 of the liver are surgically removed. After PH indeed, Gadd45b 
transcription is stimulated by the TGF-β mother against decapentaplegic (SMAD) 
pathway and the TNF-α–NF-κB pathway (Ohmura et al, 1996). After PH, TNF-α 
stimulates NF-κB activation, NF-κB in turn, activates Gadd45b transcription. TGF-β 
instead, can induce Gadd45b transcription by activating SMAD3 and SMAD4 (Major 
and Jones, 2004).  Upon induction during PH, Gadd45b inhibits MKK7, thus inhibiting 
JNK phosphorylation. JNK phosphorylation starts to decrease at around 8 hours in WT 
mice, whereas Gadd45b-/- mice display enhanced phosphorylation even after 72 hours, 
highlighting the important difference between transient and persistent JNK activation in 
liver proliferation after PH (Papa et al, 2008). TNF-α is a critical player in this process 
since mice lacking TNF-α receptor also fail to regenerate liver upon PH and fail to 
upregulate Gadd45b  (Papa et al, 2008). 
However, the effects of Gadd45b on hepatocyte proliferation are highly dependent on the 
stimulus used to induce liver proliferation. Indeed, when mice are challenged with 
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TCPOBOP, an activator of the constitutive androstan receptor (CAR) pathway, 
TCPOBOP stimulates rapid liver growth by priming hepatocytes for cellular proliferation. 
Contrary to PH, this effect is direct and does not require any prior physical liver injury 
(Tian and Locker, 2013). This process is called hyperplasia and usually is triggered by 
toxic exposure. This enhanced cell division makes the liver presumably more efficient in 
the detoxification process. Gadd45b induction after TCPOBOP stimulation is abrogated 
in CAR-/- mice, but remains the same in tumor necrosis factor receptor (TNFR) TNFR1-/- 
TNFR2-/- and TNFR3-/- indicating that PH and CAR induce Gadd45b expression through 
different pathways (Columbano et al, 2005). Gadd45b-/- mice display enhanced 
proliferation after TCPOBOP challenge as demonstrated by the doubling of Cyclin D1 
expression (Tian et al, 2011).  
However, Gadd45b expression is not always induced during liver stress. For instance, 
hepatitis C virus (HCV) infection causes inflammation, hepatocyte loss, compensatory 
proliferation and enhanced TNF-α activation, but contrary to the two cases described 
above Gadd45b expression is not induced in this case (Higgs et al, 2010). 
These findings highlight that Gadd45b lacks an intrinsic role during liver challenges, but 
rather, that the role this protein might play is extremely dependent on the stimulus used to 
induce liver stress and the extracellular milieu.  
Gadd45a is also induced by many stimuli inducing liver stress. Increase in Gadd45a liver 
expression has been detected with hepatic carcinogens such as 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) and DMBA (Hollander et al, 2001; Su et al, 2002; 
Locker, 2003; Fletcher 2005). In liver, Gadd45a expression is regulated by genes such as 
p53, breast cancer 1 (BRCA1), nuclear receptor N-methyl D-aspartate receptor subunit 
2C (TR4/NR2C) and forkhead box O2A  (FOXO2A) (Zhan et al, 1998; Jin et al, 
2000;  Yan et al, 2012). Expression of Gadd45g appears to be downregulated during liver 
hypertrophy and also is found to be deregulated in 65% of human HCC (Sun 2003 et al; 
Frau et al, 2012).  
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4	Signaling	pathways	in	HCC	
 
Numerous signaling pathways have been found to be altered during HCC development. 
Most importantly, in recent years the importance of the crosstalk between hepatocytes 
and Kupffer cells during DEN-induced HCC has been highlighted. Alteration of the same 
pathway can have dramatic opposite effects on HCC development depending on the cell 
type carrying the alteration.  
 
4-1	NF-κB	pathway	
 
The NF-κB transcription factor family in mammals consists of five proteins, p65, c-Rel, 
RelB, p105/p50 and p100/p52. In normal conditions, they form dimers that are held in the 
cytoplasm through their interaction with inhibitor of NF-κB (IκB) proteins.  IκB kinase 
(IKK) complex, which consists of 2 catalytic subunits, inhibitor of nuclear factor kappa-B 
kinase subunit alpha  (IKKα) and inhibitor of nuclear factor kappa-B kinase subunit beta  
(IKKβ) (Hoffman et al, 2006) can phosphorylate IκB inducing degradation of it. Once 
activated NF-κB dimers can translocate into the nucleus and activate a huge array of 
genes mediating processes like cytokine secretion and antiapoptotic activity (Li Q et al, 
1999). 
Mice lacking Ikkβ only in hepatocytes exhibit a notable increase in hepatocarcinogenesis 
induced by DEN and Ikkβ-/- hepatocytes are unable to translocate NF-κB dimers into the 
nucleus (Maeda et al, 2009). Ikkβ-/- mice display a great extent of hepatocyte death 
following DEN injection, this death in turn, results in enhanced compensatory 
proliferation to restore liver mass. Furthermore, a greater level of ROS accumulation can 
be seen in Ikkβ-/- mice, as the defect in NF-κB activation results in impaired transcription 
of anti-oxidant genes. These results reveal that, at least in hepatocytes, NF-κB pathway is 
associated to a tumor suppressive role by promoting the upregulation of antioxidant and 
antiapoptotic genes  (Kamata et al,2005). 
Another paradoxically opposite result can, however be observed when Ikkβ is deleted in 
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both hepatocytes and hematopoietic-derived Kupffer cells. In this case, upon DEN 
injection carcinogenesis is strongly inhibited compared to WT mice. This phenotype is 
the result of impaired production of protumorigenic cytokines such as IL-6 in Kupffer 
cells (Maeda et al, 2009). Thus, depending in which cells NF-κB pathway is inactivated, 
opposite results can be observed. 
Many of the studies of HCC pathways have been done using the DEN chemical model. 
When mice carrying multi drugs resistance gene 2 (MDR2) mutation, which show 
spontaneous low-grade chronic inflammation eventually leading to HCC development, 
are crossed with mice expressing a non-degradable form of IkB〈, the resulting mice 
display reduced HCC development (Pikarsky et al, 2004). Indicating that the role of NF-
κB in HCC development is highly dependent on the model used to perform the study. 
 
4-2	IL-6	
 
IL-6 is one of the best-characterized proinflammatory cytokines and is produced by a 
variety of cells such as T, B-lymphocytes, Kupffer cells, fibroblasts, monocytes and 
keratinocytes (Ataie-Kachoie et al, 2013). Processes regulated by this cytokine include 
acute phase response, inflammation and positive regulation of cellular growth (Hassan et 
al, 1995). Its transcription can be induced by bacterial lipopolysaccharides (LPS), TNF-α, 
EGF and cytokines such as IL-1α. Once bound to its receptor, it mediates a wide plethora 
of cellular effects by the activation of the JAK-STAT3 cascade, whose effects are 
described below. Deregulation of IL-6 pathway has been observed in diseases such as 
Chron (Neurath et al, 2011) and Alzheimer (Cacquevel et al, 2004). IL-6 is upregulated 
in various human tumors, such as lung, prostate, breast, pancreas and ovarian, and 
elevated IL-6 levels are known indicator of poor prognosis on these malignancies 
(Heikkila et al, 2008). IL-6 contributes to tumor development by mediating the activation 
of oncogenic pathways such as phosphatidylinositol-4,5-bisphosphate 3-kinase 
(PI3K)/AKT and Ras/Mapk (Grivennikov et al, 2008). IL-6 is critical for inducing HCC 
development in the DEN model. Indeed, necrotic hepatocytes produce IL-1α, which in 
turns activates Kupffer cells to produce IL-6. Mice null for IL-6 show a reduction in DEN 
induced HCC when compared to WT mice. Furthermore, dietary or genetic induced 
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obesity promotes DEN induced HCC, and this promotion is abrogated in IL-6-/- mice, 
indicating that IL-6 play a conserved tumor suppressive role in HCC, independent of its 
etiology (Naugler et al, 2007). IL-6 can also be responsible for the HCC related 
difference between males and females, as ablation of IL-6 abolishes the sex-related 
differences in HCC. This is due to the fact that, in female mice, estrogen hormones 
decrease IL-6 expression (Shi et al, 2014). In humans, high levels of IL-6 is serum of 
patients with hepatitis B correlate with increased probability of HCC development 
(Nakagawa et al, 2009).  
4.3	JAK-STAT	signaling	
 
JAK-STAT pathways are important components of the cytokine signaling network. JAK 
proteins usually interact with the intracellular domain of the cytokine receptors, which 
undergo conformational changes upon binding their respective ligand. This conformation 
change causes the displacement of the JAK proteins, which can activate the STATs by 
phosphorylation. The STAT family of proteins is composed by seven members, and 
STAT3 is recognized as a key component in the IL-6 signaling cascade (Yoshimura et al, 
2006; Yu et al, 2009). Following IL-6 binding to its receptor STAT3 translocate into the 
nucleus activating genes mediating IL-6 driven responses (Aggarwal et al, 2009). In 
addition to IL-6 however, many other factors, such as EGF, HGF, oncostatin-M (OSM), 
platelet derived growth factor (PDGF) are known to activate STAT3 expression (Abroun 
et al, 2015). STAT3 is constitutively activated in head and neck squamous cell carcinoma, 
breast, lung cancer and myeloma cell lines. STAT3 activation regulates numerous genes 
involved in cellular proliferation and survival, such as (B-cell lymphoma-extra large) 
BCL-XL, myeloid leukemia cell differentiation protein (MCL-1), Cyclin D1 and C-Myc 
(Murray et al, 2007; Levy et al, 2006; Bowman et al, 2001). STAT3 mutations are rarely 
found in cancers, and its downregulation seems to be due to mutations in its upstream 
effectors. For instance, STAT3 activation in epithelial cancer is due to aberrant IL-6 
expression (Maehara et al, 2000). Activated nuclear STAT3 is found in 60% of human 
HCCs, and SOCS3 which suppresses STAT3 activity, is found to be deregulated (He et al, 
2006; Hogata et al, 2009). STAT3 ablation in hepatocytes prevents DEN induced HCC 
development, and mice overexpressing IL-6 and IL-6 receptor spontaneously develop 
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tumors displaying enhance STAT3 activation (He et al, 2006). 
Furthermore, some studies have shown that STAT3 participates with NF-κB in the 
regulation of numerous genes (Yu et al, 2009). Indeed, many of the genes associated with 
NF-κB oncogenic activity can be preferentially activated when NF-κB interacts with 
STAT3 (Lee et al, 2011). STAT3 furthermore has been shown to maintain RelA in the 
nucleus in virtue of their physical interaction, further stimulating the transcription of NF-
κB target genes (Lee et al, 2009). 
 
4.4	The	MAP	kinase	cascade	
  
Mitogen-activated protein kinases (MAPKs) control a wide array of cellular responses, 
such as growth, proliferation, differentiation and apoptosis, depending on cell type and 
stimulus. Their deregulation is known to cause numerous diseases and to contribute to 
cancer development.  
Given their pivotal role in eukaryotic physiology, they are activated by a wide plethora of 
extracellular stimuli. This activation requires ligand-induced activation of specific 
membrane-bound receptors, such as cytokine, tyrosine and serine-threonine kinase 
receptors. Exposure to stresses such as ionizing radiation, osmotic shock and oncogene 
expression can also trigger the MAPK pathway  (Kyriakis and Avruch, 2012). 
ERK, Jun N-terminal kinases (JNK) and p38 MAPK  are the terminal effectors of the 
MAPK cascade, mediating many of the processes typically associated with MAPK 
activation. They are activated by phosphorylation mediated by upstream kinases, whose 
activity is also regulated by phosphorylation.  Signal transduction occurs by sequential 
phosphorylation of the MAP kinase kinase kinases (MAP3Ks), which activate MAP 
kinase kinases (MAP2Ks), which in turn phosphorylate MAPKs (Keshet and Seger, 
2010). Dual phosphorylation on a conserved threonine (T) and tyrosine (Y) in a 
conserved T-X-Y motif, in an activation loop of the subdomain VIII mediates MAPK 
activation. This specific phosphorylation mediates conformational changes stabilizing the 
activation loop in an open conformation which enables substrate binding and 
phosphorylation (Cuenda and Rousseau, 2007). 
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Figure I-5:  Canonical mammalian MAPK signalling pathways (Arthur and Ley, 2013).  
 
4.4.1	JNK	Signaling	
			
There are three members of the JNK family: JNK1 and JNK2, expressed ubiquitously in 
tissues, and JNK3, expressed primarily in the brain (Davis, 2000).  JNK1 and JNK2 play 
overlapping, but not identical, roles in various cellular processes. Half of the human HCC 
display overactivated JNK (Hui et al, 2008) and pharmacological inhibition of JNK 
suppresses DEN-induced HCC (Mucha et al, 2009) and growth of HCC xenograft in mice. 
Moreover, JNK1-/- mice display reduced HCC following DEN administration (Sakurai et 
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al, 2006).  These evidences clearly point out to an important function of JNK in the 
promotion of HCC. Follow-up studies demonstrate that JNK1 promotes HCC by 
upregulation of the C-Myc oncogene and a downregulation of p21 (Hui et al, 2008). 
Overactivation of the JNK pathway might also be linked to the higher tumor incidence 
in IκB-/- mice, as decreased NF-κB activity causes increased ROS accumulation, which in 
turn has been shown to extend JNK activation by inhibiting JNK phosphatase activity 
(Kamata et al, 2005).  
However, differences between DEN-induced HCC in mouse model carrying whole body 
deletion of JNK and cell type specific JNK deletion can be remarkable. Hepatocyte 
specific ablation of both JNK1 and JNK2 has been shown to increase DEN-induced HCC, 
whereas combined deletion of JNK1 and JNK2 in hepatocytes and nonparenchymal cells 
restores the DEN-mediated HCC resistance seen in whole body JNK1-/- mice (Das et al, 
2011). As hepatocyte-specific JNK deletion increases the development of HCC, these 
facts indicate that JNK deletion in nonparenchymal cells is required to reproduce the 
observed HCC resistance showed in JNK1-/- mice. A recent study done in mice carrying 
myeloid cell-specific JNK deletion confirms that JNK expression in this specific cell type 
is required for HCC development, as mice carrying JNK deletion specifically in myeloid 
cells are resistant to DEN induced HCC, recapitulating the phenotype observed in JNK1-/- 
mice (Han et al, 2016). These findings indicate the importance of the crosstalk between 
hepatocytes and myeloid cells during HCC development and that JNK performs cell type 
specific functions during HCC development.  
4.4.2	p38	family	
Four members are part of the p38 MAPK family, p38α, p38β, p38γ and p38δ (Han et al, 
2007). Among them p38α is the most abundant in various cell types.  p38 is mainly 
activated by the MAP2K mitogen-activated protein kinase kinase 3 (MKK3) and 
mitogen-activated protein kinase kinase 6 (MKK6). A wide body of evidence suggests 
that p38α acts as a tumor suppressor in many contexts. It appears to exert this function by 
inhibiting cell cycle progression and inducing apoptosis (Dolado et al, 2008). In many, 
but not all, contexts p38 seems to exert a function in antagonizing JNK activity. For 
instance, JNK activation is impaired in Mkk7-/- cells, but its activation can be restored by 
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threating mouse embryonic fibroblasts (MEFs) with p38〈 and p38® inhibitors (Wada et 
al, 2008). p38α deficient myoblast are unable to differentiate due to an increased 
activation of the JNK/jun pathway (Perdiguero et al, 2007). Treatment of mice with LPS 
also induces JNK activation in p38 deficient livers correlating with increased activation 
of MKK3, MKK4 and MKK6 (Heinrichsdorff et al, 2008). 
Fetal hematopoietic cells and embryonic fibroblasts from p38α deficient mice show 
increased proliferation associated with increased activation of the c-jun/JNK pathway. 
The same overactivation of this pathway is observed in the liver of these animals when 
HCC is induced by DEN injection. Human HCC samples display enhanced p38 activity 
compared to non-tumoral tissues (Iyoda et al, 2003), and hepatocyte-specific p38α null 
mice are prone to DEN-induced HCC development, highlighting the role of p38α in 
promoting resistance to HCC. In the same mice, p38α deletion leads to overactivation of the JNK-C-jun pathway and inactivation of either c-jun or JNK suppresses the 
increased proliferation of p38α deficient hepatocytes and tumor cells (Hui et al, 2007). 
These data clearly suggest the important role p38 plays in antagonizing JNK activity 
during liver stress. The same tumor inhibitory function of p38α in HCC development was 
confirmed in mouse models where HCC is induced by liver cirrhosis, p38α was also 
found to inhibit HCC by preventing ROS accumulation and liver damage (Sakurai et al, 
2013). 
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OBJECTIVES	
 
 
The principal objective of this thesis has been to study the role of Gadd45b in the 
development of hepatocellular carcinoma. In addition, we initiated a study about the 
function of Gadd45a in liver carcinogenesis. 
 
In order to achieve this goal we had the following partial aims: 
 
1. To examine the in vivo contribution of Gadd45b and Gadd45a in liver tumor 
development in DEN-induced HCC model. 
 
2.  To study the role of Gadd45b and Gadd45a in hepatocytes cell death following 
DEN injection. 
 
3. To analyse the Gadd45b and Gadd45a involvement in the DEN-induced 
compensatory proliferation. 
 
4. To investigate the implication of Gadd45b in liver inflammation by analysing 
immune cells infiltration, cytokines production and cell signalling in the DEN-
treated livers. 
 
5. To assess if specific-ablation of Gadd45b in monocytes/Kupffer cells 
differentially affects apoptosis, cytokine production and compensatory 
proliferation upon DEN injection. 
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MATERIALS	AND	METHODS	
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1.ANIMAL	MODELS	
	
Gadd45a-/- and Gadd45b-/- mice were generated on a mixed 129/C57BL/6 genetic 
background (Hollander et al,1999; Gupta, et al, 2005). Gadd45a-/- and Gadd45b-/- mice 
on a pure C57BL6/6 background were generated by backcrossing for ten generations. 
Mice were handled according to national and European Union animal care standards and 
the experiments were approved by the CNB Ethical Committee. 
1.1	DEN-INDUCED	CARCINOGENESIS	
 
Chemically induced DEN tumorigenesis is a widely used protocol, which enables the 
development of HCC in mice. It consists of a single intraperitoneal injection of DEN in 
male mice. This protocol relies on an initial wave of apoptosis followed by compensatory 
proliferation, which enables replication of cells with damaged DNA. For this protocol, 
fifteen-day-old male mice on a 129/C57BL/6 genetic background were injected with 25 
mg/kg DEN (Sigma). After nine months, mice were sacrificed and their livers were 
removed and analyzed for presence of HCCs and subjected to histological and 
immunological analysis.  
1.2	DEN-ACUTE	MODEL	
 
This model was used to check the initial apoptotic and proliferative responses induced in 
liver following DEN injection. These responses happen in the first 48 hours following 
DEN injection.  Two months old C57BL/6 wild-type (WT) mice, Gadd45a-/- and 
Gadd45b-/- mice were injected with 100 mg/kg of DEN and sacrificed 48 hours to 
monitor apoptosis and proliferation, and after 5 hours to assess RNA expression. 
1.3	BONE	MARROW	TRANSPLANT	
 
We wanted to create a murine model whose liver had WT hepatocytes and Gadd45b-/- 
Kupffer cells and viceversa, to determine whether the phenotype observed in Gadd45b-/- 
mice after injection was due to the lack of Gadd45b in Kupffer cells, hepatocytes or in 
both. All the experiments were carried out in the C57BL/6 background, in order to 
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eliminate issues related to bone marrow compatibility.  Furthermore, in order to 
assess reconstitution efficiency, male mice were used as the donors and female mice as 
the recipients. This enables to evaluate the extent of bone marrow reconstitution in the 
recipient female mice by amplifying the specific male SRY gene, located on the Y 
chromosome. Donor cells were collected after sacrificing WT or Gadd45b-/- mice and 
extracting bone marrow cells from femur and tibiae by inserting a needle syringe in the 
bone cavity and performing several washes with a cold PBS-EDTA solution. Cells were 
filtered through a 70 µm filter to avoid clumps formation and four million cells were 
injected intravenously via tail vein into the recipient mice. Previously, two months old 
recipient mice were lethally irradiated with 10 grays at 24 hours before 
transplant.   Engraftment of the transplanted bone marrow cells was allowed to take place 
for a minimum of six weeks before animals were sacrificed. WT mice 
were reconstituted with Gadd45b-/- bone marrow and Gadd45b-/- mice were reconstituted 
with WT bone marrow. Irradiated WT mice reconstituted with WT bone marrow were 
used as a control. 
2.		GENERAL	METHODS	
 
2.1	PROTEINS	AND	RNA	SAMPLES	PREPARATION		
In order to extract protein and RNA from murine tissue, mice were sacrificed and liver 
was collected and mechanically disrupted in liquid nitrogen. Tissue powder was 
processed for protein and RNA extractions. Proteins were extracted using a cell signaling 
lysis buffer (Ref 9803). Protein concentration was assessed by using the MicroBCA 
protein assay kit (Thermofisher Ref 23235). For RNA preparation tissue powder was 
homogenized in TRI Reagent (Sigma Aldrich) and RNA-containing fraction was mixed 
with isopropanol for RNA precipitation. After. double precipitate washing with 70% 
ethanol and dissolving in RNase-free water, the RNA concentration was measured with 
Nanodrop spectrophotometer. 
2.2.	IMMUNOBLOTTING		
Proteins were denatured using standard loading buffer, as described in Table M-1, for 10 
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minutes at 95°C. Polyacrylamide gel electrophoresis (PAGE) was performed according to 
a common procedure. Denatured protein samples, at volumes corresponding to equal 
protein amounts (40 µg), were loaded into 12.5% polyacrylamide gel wells and proteins 
were separated in a running buffer (Table M-2) connected to a source of electrical field 
(120 V, for 2 hours, at RT). Separated proteins were electro-blotted onto a PVDF 
membrane previously activated in methanol for 2 minutes, using a transfer buffer (Table 
M-3). The membrane was later incubated with a blocking solution, containing 5% 
skimmed milk dissolved in a TBS buffer (Table M-4) with 0.1% of Tween 20, at RT. The 
blocked membrane was incubated overnight with a primary antibody (Table M-5) diluted 
in a blocking solution at 4°C. Protein expression was addressed using HRP-Conjugated 
secondary antibodies. Band density was determined using image studio lite software. 
 
LOADING	BUFFER	4X	
Reactive	 Concentration	
Tris	-HCL	 20	mM	PH	7.4	
SDS	 150	mM	
Glicerol	 0,05%	
Ditioreitol	 1M	
β−mercaptoetanol	 4%	
Blue	Bromophenol	 1%	
DILUTED	IN	WATER	
TABLE	M.1	-	Loading	buffer	4x	
Components	
	 	 RUNNING	BUFFER	10X	
Reactive	 Amount	
Tris		 30	gr	
Glicine	 144	gr	
SDS	 10	gr	
DILUTED	IN	1	LITER	OF	WATER		
TABLE	M.2	-	Running	buffer	10x	
Components	
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TBST	1X	
Reactive	 Concentration	
	Tris	-HCL	 20	mM	PH	7.4	
NaCl	 150	mM	
Tween20	 0,05%	
DILUTED	IN	WATER	
TABLE	M.4	–	TBST	1X	Components	
Antibody	 Secondary	 Company	 Dilution	
P-JNK	 Rabbit	 Cell	Signaling	 1/1000	
Cyclin	D1	 Mouse	 Cell	Signaling	 1/2000	
GAPDH	 Rabbit	 Cell	Signaling	 1/2000	
P-STAT3	 Rabbit	 Cell	Signaling	 1/500	
P-IκBα  Mouse	 Cell	Signaling	 1/1000	
P-MKK7	 Rabbit	 Cell	Signaling	 1/500	
P-MKK4	 Rabbit	 Cell	Signaling	 1/500	
Tot-JNK	 Mouse	 Cell	Signaling	 1/1000	
P-C-JUN	 Rabbit	 Cell	Signaling	 1/1000	
TABLE	M.5	–	Antibodies	used	in	WB	experiments	
TRANSFER	BUFFER	10X	
Reactive	 Amount	
	Tris	 58	gr	
Glicine	 29	gr	
SDS	 3,7	gr	
DILUTED	IN	1	LITER	OF	WATER		
TABLE	M.3	–	Transfer	buffer	10X	
Components	
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2.3.	IMMUNOPRECIPITATION	AND	KINASE	ACTIVITY	
 
Liver protein lysates (500 µg) were incubated O.N. with anti-p-JNK antibody (1,5 µg) at 
4°C with orbital agitation in a minimum of 200 µl lysis buffer volume. The next day 30 
µl of protein G sepharose beads (GE healthcare) were added to the solution and incubated 
for 2,5 hour in orbital agitation. Lysates were then centrifuged at 18000 x g. After being 
washed twice in lysis buffer and twice in kinase buffer (25 mM Tris, pH 7.5, 5 mM β-
glycerophosphate, 2 mM dithiothreitol, 0.1 mM Na3VO4 and 10 mM MgCl2), the samples 
were incubated at 30oC for 20 min in a 50 ul volume with 1 µg of c-jun substrate (Cell 
Signaling) and 200 µM ATP (Cell Signaling). Reaction was stopped by adding 14 µl of 
loading buffer 4x and lysates were boiled at 100°C for 5 minutes in order for the beads to 
dissociate from the antibody complex. Lysates were centrifuged at 9000 x g. Pellet was 
discarded and supernatant was used for western blot analysis.  
 
2.4.	REAL-TIME	QUANTITATIVE	PCR 
 cDNA for real-time quantitative PCR (qPCR) was generated from 0.5 µg of total RNA 
using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) in a 10 
µl of final reaction volume. The qPCR reactions were performed in triplicate using 5 µl 
of each cDNA 1/40 dilutions, 10 µM of each oligonucleotide and HOT FIREPol qPCR 
mix (Solis Biodyne) in a total volume of 8 µl in MicroAmp Optical 384-well plates 
(Applied Biosystems). PCR reactions were carried out in an ABI PRISM 7900HT 
(Applied Biosystems). The amount of amplified DNA was measured through the 
emission of light by the SYBR Green dye, intercalating in synthesized double stranded 
DNA. All samples were measured in triplicates. SDS v2.2 software was used to analyze 
results. Specific amplification was controlled by melting-curve analysis. The data were 
exported, processed to Microsoft Excel and analyzed by the comparative Ct method 
(DDCt). X-fold change in mRNA expression was quantified relative to unstimulated WT 
samples from the same experiment. Gapdh mRNA was used as a housekeeping gene. The 
sequences of the oligonucleotides used in this thesis can be found in Table M-6 
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2.5.	IMMUNOHISTOCHEMISTRY	
 
 For histological analyses, livers were fixed in 4% buffer formalin, dehydrated, embedded 
in paraffin, section (5 um) and processed for H&E staining or immunohistochemistry. 
Liver and tumor sections were deparaffinised using xylene for 20 min and rehydrated 
with 3-min incubations in ethanol at decreasing concentrations (2x 100%, 1x 90% and 1x 
70%). The antigen retrieval was performed by heating up the sections in 0.01 M citrate 
buffer (pH 6.0) for 15 min. The samples in hot citrate buffer were placed on ice for 20 
min to cool down gradually. The activity of endogenous peroxidase was blocked by 
incubating for 20 min in 3.3% of hydrogen peroxide (H2O2) in methanol at RT. To block 
unspecific proteins the sections were incubated, for 1 hour at 37°C, in 20% of goat serum 
in 3% of bovine serum albumin (BSA) in distilled water. After the blocking step, 
incubations in different primary antibodies were performed in accordance with 
manufacturer’s recommendations. The antibodies were diluted in blocking solution and 
then added onto the tissue sections that were placed in a humid chamber for an overnight 
incubation at 4°C.  Next day, the sections were washed with PBS-Tween 0.1% (Table M-
7) three times for 5 min. Biotinylated secondary antibodies were used to bind to the 
primary antibodies in accordance with their specificity during 1-hour incubation at RT. 
Image analysis and performed using the cell profiler software. 
 
 
Gene  Forward Sequence (5’ !3’) Reverse Sequence (5’ !  3’) 
Gapdh CCCATCACCATCTTCCAGGA CGACATACTCAGCACCGGC 
Il-6 GAGGATACCACTCCCAACAGACC AAGTGCATCATCGTTGTTCATACA 
IL-1α  CACCTTACACCTACCAGAGTGATTTG TGTTGCAGCTCATTTAACCAAGTG 
TABLE	M.6	–	Oligonucleotide	Sequences 
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Apoptotic cells in liver tissue were stained using terminal deoxynucleotidyltransferase 
(TdT)- mediated dUTP nick-end label (TUNEL) staining. Briefly, paraffin-embedded 
liver sections were deparaffinised and rehydrated as described above. The slides were 
washed with PBS and permeabilized in PBS containing 0.5% Triton X-100. Next, the 
sections were pre-incubated for 15 min at RT in freshly prepared TdT 1X buffer (Table 
M-8) containing 1mM cobalt (II) chloride. The TdT-based reaction was carried out in a 
humid chamber at 37°C for 1 hour in the same buffer, containing besides 3% TdT (v/v) 
(Roche, ref. 03333574001) and 2% biotin-16-dUTP (v/v) (Roche, 11093070910). After 
this the sections were washed twice with PBS containing 0.01% Tween 20. Sections were 
then incubated with streptavidin conjugated with a cyanine fluorochrome (Cy5). Nuclei 
were stained with Hoechst33342.. The slides were observed by fluorescent microscopy 
using Leica DMI 6000B microscope. Image analysis was performed using the cell 
profiler software 
. 
		
			
			
			
			
 
 
 
	
	
	
		
PBS	1X	
Reactive	 Concentration	
Sodium	phosphate	 10mM	PH	7.4	
NaCl	 150mM	
DILUTED	IN	WATER	
TABLE	M.7–	PBS	COMPONENTS	
 TdT	Buffer	5X	
Reactive	 Concentration	
BSA	 0,125%	
Tris-Buffer	PH	8.8	 125mM	
Sodium	cacodylate		
trihidrate	
1M	
DILUTED	IN	WATER	
ADJUST	PH	to	6.6	
TABLE	M.8–	TdT	buffer	5X	components	
	 44	
2.7.	IMMUNOFLUORESCENCE	
		
			
			
			
			
		
		
		
 
2.7.1	F4/80		
 
Liver tissues were frozen in liquid nitrogen. Slides were fixed in 100% cold acetone for 
10 minutes, blocking was carried out for 30 minutes using PBS containing 10% goat 
serum and 1% BSA. Slides were incubated overnight at 4°C with anti-F4/80 antibody 
(Serotec) in the blocking solution. The next day slides were incubated for 45 minutes RT 
with mouse anti-rat Cy5 (Jackson Lab), briefly washed with PBS and incubated for 10 
minutes at RT with DAPI. Slides were then observed by fluorescent microscopy using 
Leica DMI 6000B microscope. Image analysis was performed using the cell profiler 
software 
 
2.7.2	ROS	STAINING	
 
Liver tissues from mice were frozen in liquid nitrogen, slides were allowed to thaw for 2 
minutes at RT, and incubated with dihydroethidium (DHE) (10 µΜ) in PBS for 30 
minutes at 37°C.  DHE is a superoxide indicator, exhibiting	blue-fluorescence	 in	 the	cytosol	 until	 oxidized,	 where	 it	 intercalates	 within	 the	 cell's	 DNA,	 staining	 its	nucleus	 	 in	 red.	Slides were gently washed with PBS and incubated 10 minutes at RT 
with DAPI. Slides were then observed by fluorescent microscopy using Leica TCS SP5 
confocal microscope. Image analysis was performed using the cell profiler software 
3.	PRIMARY	CELLS	ISOLATION	METHODS	
3.1	PRIMARY	HEPATOCYTE	ISOLATION	
 
For hepatocyte isolation, all the solutions described below were kept in a bath at 37°C to 
equate a mouse body temperature. Mice were anesthetized with avertin and peritoneum 
was opened. A sterile thread was passed under the inferior vena cava just below the liver 
and ligated. A 24-G catheter was inserted into the inferior vena cava and the thread was 
tightly ligated. Vena porta was cut to allow the blood out of the vascular system. 
Perfusion solution (HBSS w/o Ca/Mg/phenol, Invitrogen) was sent to the liver through 
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the catheter for 4 minutes at a flow of 2,5 ml/min. Perfusion solution was then switched 
with collagenase solution (Williams E media containing 0,6 mg/ml collagenase type IV, 
Sigma). Collagenase solution was sent to the liver with a flow of 4 ml/min for 12 minutes. 
Liver was excised, put in a 60 mm dish and cells were disgregated by gentle 
counterstriking with two 1 ml pipettes. Suspension was filtered through a cell strainer and 
passed into a falcon tube.  Cells were centrifuged at 35x g for 10 minutes. Supernatant 
was discarded and pellet was resuspended in HBSS. Live and dead hepactocytes were 
separated by a 10 minutes, 35 x g centrifugation in iso-osmotic Percoll (45 ml Percoll, 4,5 
ml 10x HBSS, 0,5 ml HEPES). Supernatant, consisting of dead hepatocytes was 
discarded and the pellet was resuspended in HBSS and used for cell cultures.  
 
 
3.2	KUPFFER	CELL	ISOLATION	
 
For Kupffer cells, the isolation procedure was identical to the hepatocyte protocol until 
the first centrifugation. At this point, hepatocyte pellet was discarded and supernatant was 
centrifuged at 650 x g for 10 minutes. The resulting pellet consisted mainly of Kupffer 
cells. Pellet was resuspended in 10 ml HBSS and carefully layered on top of a 50%/25% 
percoll gradient and centrifuged at 1800 x g for 15 minutes. Upper layer, consisting 
mostly of dead cells, was removed and the middle layer, containing a ring of alive 
Kupffer cells was carefully transferred in a new 50 ml falcon tube and HBSS was added 
to reach 50 ml volume. Solution was centrifuged 650 x g for 10 minutes and the resulting 
pellet was used for cell cultures. 
4.	FLOW	CYTOMETRY	METHODS		
 
4.1	NEUTROPHILES	DETECTION	
 
The protocol was identical to the Kupffer cell isolation protocol described above until the 
first centrifugation at 650 x g for 10 minutes. The resulting pellet consists mainly of 
Kupffer cells but a small population of infiltrating neutrophils can be identified by flow 
cytometry. Cells in the pellet were counted and placed at a density of 50000 cells/well in 
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a 96 well plate. Cells were centrifuged at 550 x g for 5 minutes and incubated 30 minutes 
at 4°C with anti Ly6C and Ly6G antibodies conjugated with FITC and PE respectively. 
Cells were centrifuged at 550 x g for 5 minutes, and cells were passed through the flow 
cytometer (Gallios, Beckman) and double positive cells were identified using the Kaluza 
software 	
5.	CELL	CULTURE	METHODS	
5.1	HEPATOCYTE	CULTURE	
 
Hepatocytes were plated in 96 wells at a density of 12500 cells/well. Cells were cultured 
in Hepatocyte Feeding Media (DMEM/F12 GlutaMAX supplemented with BSA, HEPES, 
Na-pyruvate, sodium bicarbonate, proline, galactose, ITS and EGF). Cells were kept in 
an incubator at 37°C and 5% CO2. 
5.2	KUPFFER	CELL	CULTURE		
 
Kupffer cells were plated in 96 well plates at a density of 120000 cells/well. Cells were 
cultured in RPMI, supplemented with 10% FBS, non-essential amino acids, sodium-
piruvate, L-glutamine.Cells were kept in an incubator at 37°C and 5% CO2. 
 
5.3	IN	VITRO	CYTOKINE	PRODUCTION	ASSAY	
 
Kupffer cells at a density of 120000 cells/well were cultured in a 96 well plate. Cells 
were serum starved O.N. in 0,5% serum RPMI media. The next day 10% serum RPMI 
media containing either 100 ng/ml of IL-1α or IL-1β was added to the cells, supernatant 
was collected after 24 hours and IL-6 secretion was measured with IL-6 ELISA kit 
(Affimetrix) according to the manufacturer protocol.  
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5.4	LDH	RELEASE	ASSAY	
 
Hepatocytes were isolated and kept in culture for 2 days, on day 3 feeding media 
containing either 100 ng/ml TNF-α or TGF-β (R&D) was added. 24 hours later, 
supernatant was collected and LDH was measured with LDH release assay (Promega) 
according to the manufacturer protocol.  
6.	STATISTICAL	ANALYSIS		
 
For statistical analyses GraphPad Prism 7 was used. Differences between WT and 
Gadd45b-/- or Gadd45a-/- mice were examined for statistical significance using the 
Student´s test. Differences were considered statistically significant for (*) P<0.05  (**) 
P<0.01 (***) P<0.001. In figure R1-B and R7-B, Fisher test was applied to compare 
differences between tumor-positive mice of different genotype. If not stated otherwise, 
non-significant differences between the corresponding groups from different genotypes 
have not been shown on the graphs. 
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1.1	Gadd45b	is	required	for	DEN-induced	tumorigenesis	
 
To address the role of Gadd45b in HCC development, a cohort of wild type and 
Gadd45b-/- mice was injected with the carcinogen DEN. Mice were sacrificed after nine 
months to assess tumor development (Fig. R-1A). Notably, we found significant 
differences in the percentage of tumor free mice between WT and Gadd45b-/- mice. In 
fact, 30% of all Gadd45b-/- mice versus only 3% of wild type mice did not display any 
sign of tumorigenesis after exposure to DEN (Fig. R-1A,B). Furthermore, when the 
groups of tumor positive animals were compared, 41% of wild type mice developed 
between 10 and 20 tumors, and this number dropped to less than 10% for Gadd45b-/- 
mice. Most importantly, no mice in Gadd45b-/- genotype developed more than 20 tumors, 
while this number was as high as 20% in the wild type background (Fig. R-1C). The 
liver/bodyweight ratio can be taken as an indication of the liver tumoral mass, indeed, 
tumors present in the liver increase liver mass, augmenting the liver/bodyweight ratio. 
This number was significantly lower in Gadd45b-/- mice compared to WT mice (Fig. R-
1D), indicating that Gadd45b-/- tumors had lower cellular mass than WT tumors. 
Adenomas are benign tumors of the liver, and only a small percentage can evolve into 
HCC over time. Benign tumors, by definition, lack the ability to invade neighboring 
tissues or metastasize and, therefore, cannot be defined as cancerous. Remarkably, HCC 
could be identified in 40% of the WT mice whereas no mouse belonging to the Gadd45b-
/- genotype displayed any sign of HCC (Fig. R-1E). All the tumors identified in Gadd45b-
/- mice were adenomas. We therefore can say that Gadd45b-/- mice were HCC free after 
nine months of exposure to DEN.  These evidences point out to a new and unexpected 
tumor promotive role of Gadd45b in DEN-induced tumorigenesis.  
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Figure R-1: Liver tumor formation in WT and Gadd45b-/- mice after DEN treatment. 
Two weeks old wild-type and Gadd45b-/- mice were treated with a single intraperitoneal 
injection of DEN (25 mg/kg) and livers were harvested after nine months. (A) 
Representative picture of DEN-induced liver tumors in wild-type (n=32) and Gadd45b-/- 
(n=39) mice. (B) The percentage of tumor-free mice after 9 months of exposure to DEN. 
Statistically significant differences between WT and Gadd45b-/- mice are indicated (**) 
P<0,01. P value is from a Fisher´s exact test. (C) The percentage of tumor-positive mice 
after nine months. (D) The liver/body weight ratio was calculated and expressed as the mean 
percentage  ± S.E.M. Differences between WT and Gadd45b-/- mice were examined for 
statistical significance using the Student´s test, (**) P<0,01. (E) The percentage of HCC and 
adenomas nine months after DEN injection in WT (n=8) and Gadd45b-/- mice (n=9). 
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1.2	Gadd45b	deficiency	prevents	hepatocyte	death	and	compensatory	
proliferation	following	DEN	administration	
	
It is well known that carcinogen induced hepatocyte cell death and subsequent cellular 
proliferation are crucial processes leading to tumor development. In the case of DEN-
treatment, both events are initiated in the first 48 hours after DEN administration. As 
Gadd45b-/- mice develop no tumors upon DEN injection, we reasoned that early induction 
of Gadd45b could be critical for the onset of these processes. Indeed, Gadd45b mRNA 
expression was significantly increased upon DEN injection (Fig. R-2A). We examined  
hepatocyte death in WT and Gadd45b-/-  mice after exposure to DEN. Sections of liver 
were stained for cell death using the TUNEL assay (Fig. R-2B). In addition, we studied 
caspase activation by immunoblot analysis. We found that lack of Gadd45b in mice 
impaired cell death. TUNEL staining and cleaved caspase-3 expression revealed reduced 
hepatocyte death in DEN-treated Gadd45b-/- mice compared to WT mice (Fig. R-2B).The 
observed decrease in cell death could be the result of defects in the apoptotic mechanisms 
leading to hepatocyte death in Gadd45b-/- mice. To test this hypothesis, we purified 
primary hepatocytes from WT and Gadd45b-/- mice and treated them with TNF-α and 
TGF-β, two bona fide proapoptotic cytokines. Apoptosis was analyzed by measuring 
lactate dehydrogenase (LDH) released in the media. LDH is a soluble enzyme found 
inside living cells that is released in the extracellular space when cell membrane integrity 
is compromised. In vitro, purified primary Gadd45b-/- hepatocytes showed reduced 
sensitivity to TNF-α and TGF-β induced cell death (Fig. R-2C) pointing out to an 
intrinsic resistance mechanism of apoptosis independent from extracellular milieu. The 
liver is a body organ capable of regeneration, the reduced hepatocyte cell death of 
Gadd45b-/- mice upon DEN injection might affect compensatory proliferation, a 
mechanism required to induce the initial mutations eventually leading to cancer 
development. In the initial phase of DEN-induced carcinogenesis, the apoptotic and 
proliferative waves are almost simultaneous and expression of proliferative markers such 
as Cyclin D1 and Ki67 can be observed 48 hours upon injection. In many cases, a lower 
apoptotic response results in a decrease in the compensatory proliferation. We therefore 
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examined the proliferative response after DEN-treatment in WT and Gadd45b-/- mice. 
The lack of Gadd45b in mice caused both reduced positivity to Ki67 immunostaining and 
reduced amount of Cyclin D1 by western blot analysis (Fig. R-2D). In summary, our data 
indicate that Gadd45b expression is required for hepatocyte cell death and subsequent 
compensatory proliferation triggered by DEN-induced stress.  
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Figure R-2 Lack of Gadd45b decreases hepatocyte death and proliferation after 
DEN injection. (A) Quantitative RT-PCR showing Gadd45b mRNA expression in liver 
of WT mice 5 h after 100 mg/kg DEN treatment in vivo. The statistical data for Gadd45b 
mRNA was normalized to Gapdh mRNA. Data represent mean ± S.E.M. of three 
independent experiments, n=3 mice in each group, (P<0,01). (B) Top, TUNEL stain of 
livers from WT and Gadd45b-/- mice 48 h following 100 mg/kg DEN injection, n=3 mice 
per genotype. Statistical analysis of double positive cells with 5 fields of view for each 
group, data represent mean  ± S.E.M. (P<0,01). Bottom, Cleaved Caspase 3 expression 
level (CL-caspase3), in the same conditions as the top figure, was analyzed by Western 
blot (n=6 for DEN-treated groups, n=2 for untreated controls) and GAPDH expression 
was used as a loading control. This result is representative of three independent 
experiments. Densitometry analysis of cleaved caspase 3 signal is normalized to GAPDH. 
Data represent mean  ± S.E.M. (P<0,05). (C) LDH release in the supernatant of WT and 
Gadd45b-/- primary hepatocytes either untreated or treated for 24 h with 100 ng/ml TNF-
α and TGF-β (n=3 in all groups), data represent mean  ± S.E.M. (P<0,001). (D) Top, 
analysis of hepatocyte proliferation by immunostaining for Ki67 of livers from WT and 
Gadd45b-/- mice 48 h following 100 mg/kg DEN injection, n=3 mice per genotype. 
Statistical analysis of Ki67 positive cells with 5 fields of view for each group, data 
represent mean  ± S.E.M. (P<0,05). Bottom, expression of Cyclin D1 was monitored by 
Western blot analysis and GAPDH expression was used as a loading control. 
Densitometry analysis of Cyclin D1 signal is normalized to GAPDH. Data represent 
mean  ± S.E.M. (P<0,05). 
 
 
 
1.3	Reduced	IL6	production	in	Gadd45b-/-	mice	upon	DEN	administration	
 
Necrotic hepatocytes release a vast array of inflammatory mediators, among those, IL-
1〈  is known to be necessary, but not sufficient, to activate Kupffer cells to release IL-6. 
This cytokine stimulates hepatocyte division, connecting cell death to cellular 
proliferation. We therefore examined the production and expression of inflammatory 
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cytokines in WT and Gadd45b-null mice. Whereas IL-6 serum level in Gadd45b-/- mice is 
significantly lower compared to WT mice, upon DEN injection, only a non-significant 
trend of decrease can be found for the IL-1α  (Fig. R-3A). Since IL-1α  is mainly 
produced by hepatocytes and IL-6 by Kupffer cells, we analyzed whether lack of 
Gadd45b might affect their expression in both cell types. When hepatocytes and Kupffer 
cells from WT and Gadd45b-/- mice were purified upon DEN injection, quantitative RT-
PCR analysis showed reduced IL-6 gene transcription in Gadd45b-/- mice compared to 
WT mice. However, transcription of hepatic IL-1α  remained unaltered between the two 
groups (Fig. R-3B). Therefore, reduced IL-6 expression in Gadd45b-/- mice can account 
for the reduced compensatory proliferation upon DEN genotoxic stress.    
 
 
 
Figure R-3.  Gadd45b is required for IL-6 production induced by DEN treatment. 
A) Luminex assay showing cytokines serum levels in WT and Gadd45b-/- mice at the 
indicated time points, after 100 mg/kg DEN injection . Left concentration of IL-1α  (n=3 
for each genotype and time), right, concentration of IL-6, (n=3 for each genotype and 
time; P<0,001). Data represent mean ± S.E.M. (B) WT and Gadd45b-/- mice were 
injected with DEN 100 mg/kg (n=3 each group), liver was harvested after 5 hours and 
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mRNA expression was analyzed in hepatocytes and Kupffer cells, using uninjected WT 
mice as control. Left, IL-1α  expression in hepatocytes from WT and Gadd45b-/- mice 
compared with uninjected WT mice was analyzed by quantitative RT-PCR. The 
statistical data for mRNA was normalized to β-actin mRNA. Data represent mean ± 
S.E.M. Right, IL-6 expression in Kupffer cells from WT and Gadd45b-/- mice compared 
with uninjected WT mice was analyzed by quantitative RT-PCR. mRNA was normalized 
to β-actin  (P<0,001), data represent mean ± S.E.M. 
 
 
1.4	Gadd45b	deficiency	reduces	inflammation	but	not	oxidative	stress	upon	
DEN	treatment		
 
ROS generated by both initiated cells and inflammatory cells are thought to accelerate 
HCC development by inducing DNA damage and hepatocyte injury (He et al, 2011). 
Indeed, excessive ROS production promotes hepatocyte death by various mechanisms, 
including prolonged JNK activation by inactivation of JNK phosphatases (Kamata et al, 
2005). Furthermore, Kupffer cells-mediated IL-6 secretion is known to facilitate 
macrophages and neutrophils recruitment to the injury site (Kong et al, 2016).  Given the 
decrease in IL-6 observed in Gadd45b-/- mice upon DEN injection, we analyzed if 
Gadd45b  affects these processes.  After 48 hours of DEN treatment, Gadd45b-/- mice 
displayed reduced infiltrate in terms of macrophages and neutrophils (Fig. R-4A). When 
ROS production was analyzed instead, no differences (red signaling) were found between 
the WT and Gadd45b-/- genotypes, indicating that Gadd45b tumor promotive effect was 
not caused by increased oxidative stress (Fig. R-4B).  
 
	 57	
 
Figure R-4 Lack of Gadd45b reduces cell infiltration but does not affect oxidative 
stress. A) WT and Gadd45b-/- mice were injected with DEN 100 mg/kg (n=3 each group), 
livers were harvested after 5 hours and macrophages and neutrophils infiltration was 
analyzed. Top, F4/80 immunostaining: statistical analysis of F4/80 positive cells with 5 
fields of view for each group, data represent mean ± S.E.M. (P<0,05). Bottom, single-cell 
suspensions from livers are stained and analyzed by FACS for the indicated cell surface 
markers. Statistical data indicated the percentage of neutrophils identified as LY6C
high 
LY6G
high cells, data represent mean ± S.E.M. (P<0,05) of at least three independent 
experiments. (B) DHE stain of livers from WT and Gadd45b-/- mice 48 hours following 
100 mg/kg DEN injection (n=3 each group). Statistical analysis of DHE-positive cells with 
5 fields of view for each group, data represent mean ± S.E.M. 
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1.5	Gadd45b	stimulates	JNK	activity	during	DEN	induced	tumorigenesis.	
 
JNK is known to promote tumorigenesis during DEN-induced liver injury by enhancing 
Cyclin D1 expression (Sakuray et al, 2006). Interestingly in liver, cell-type specific 
deletion of JNK can have opposite effects on DEN-induced HCC development. 
Hepatocyte-specific deletion of JNK has been found to enhance the development of 
tumors following DEN-injection. However, whole liver JNK1-/- mice, carrying JNK 
deletion in both hepatocyte and nonparenchimal cells, are resistant to DEN-induced 
tumorigenesis (Sakurai et al, 2006).  Forty eight hours post DEN injection, 
phosphorylation of JNK is markedly decreased in  Gadd45b-/- mice compared to WT (Fig. 
R-5A). In the same context, kinase activity assay shows reduced activity of JNK in 
Gadd45b-/- livers (Fig. R-5B). Phosphorylation of JNK is mainly, but not only, mediated 
by its upstream MAP2K mitogen-activated protein kinase kinase 7 (MKK7) and mitogen-
activated protein kinase kinase 4 (MKK4). However, no differences could be found 
between WT and Gadd45b-/- mice in MKK7 and/or MKK4 phosphorylation,. In addition, 
the lack of Gadd45b resulted in a dysregulation of the IL-6 signalling pathway, confirmed 
by reduced phosphorylation of STAT3, and decreased NF-κB activity, consistent with the 
reduced phosphorylation of IκBα.  
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Figure R-5 Gadd45b is required for JNK and STAT3 activation after DEN 
treatment. A) Top, WT and Gadd45b-/- mice were injected with DEN (100 mg/kg). 
Phosphorylation of STAT3, MKK4, MKK7, JNK and IκBα were assessed by Western 
blot analysis. Uninjected WT mice were used as a control. Bottom, Densitometry analysis 
of proteins in the top figure. Signal is normalized to GAPDH. Values represent mean ± 
S.E.M., n=3 mice for treated groups, n=2 for the control group (P<0,05). (B) Cell extracts 
from WT and Gadd45b-/-mice were immunoprecipitated (IP) with anti-JNK antibody and 
in vitro immune complex kinase assay was performed using C-JUN as a bone fide JNK 
substrate.
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1.6	Gadd45b	expression	in	Kupffer	cells	is	required	for	IL-6	production	and	
subsequent	cellular	proliferation		
 
Specific ablation of the same gene either in hepatocytes or in Kupffer cells can have 
opposite effects on DEN-induced carcinogenesis. Lack of JNK only in hepatocytes or in 
hepatocytes and myeloid cells altogether either increases or decreases DEN-induced 
tumorigenesis, respectively (Das et al, 2011). This particular phenotype has been linked 
to IL-6 production. IL-6 is a paramount cytokine and its expression by Kupffer cells is 
required for DEN-mediated HCC development. Blockage of JNK selectively in 
hepatocyte has been found to enhance Kupffer cells mediated IL-6 secretion whereas 
combined deletion of JNK in both hepatocyte and Kupffer cells represses it. As we 
observed a blockade of JNK signaling in liver from Gadd45b-/- animals associated with 
decreased IL-6, we investigated if this phenotype is maintained when Gadd45b is 
selectively deleted in hepatocytes or in myeloid cells. As  Kupffer cells originate from 
bone marrow, we took advantage of the bone marrow transplant, where mice are lethally 
irradiated and transplanted with a donor bone marrow. Liver repopulation by Kupffer 
cells from donor origins happens within 6 weeks. We lethally irradiated Gadd45b-/- and 
WT mice and reconstitued them with WT or Gadd45b-/- bone marrow respectively, this 
enables the generation of mice carrying selective deletion of Gadd45b either in 
hepatocytes (Gadd45bΔhep) or in monocytes/Kupffer cells (Gadd45bΔKup). Upon DEN 
injection, we found that compensatory proliferation was substantially compromised in 
Gadd45bΔKup mice, as noted by decreased levels of proliferative markers Ki 67 and 
Cyclin D1 (Fig. R-6A,B). Cyclin D1 levels in these mice were equal to uninjected 
controls, whereas Cyclin D1 levels in Gadd45bΔhep were significantly increased up to 4 
folds compared to Gadd45bΔKup mice. As compensatory proliferation is mediated by IL-6, 
we analyzed IL-6 expression in these animals following DEN injection. (Fig. R-6C). IL-6 
serum level was decreased in Gadd45bΔKup compared to Gadd45bΔhep mice. Thus, 
specific deletion of Gadd45b in Kupffer cells impairs DEN induced compensatory 
proliferation by decreasing IL-6 production.  As for DEN-induced apoptosis we have 
observed no differences between Gadd45bΔKup compared to Gadd45bΔhep mice following 
DEN injection (Fig. R-6D).  
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Figure R-6 Gadd45b expression in Kupffer cells is required for efficient IL-6 
production. Reconstitution of the bone marrow in recipients Gadd45b+/+ mice with 
Gadd45b-/- donors (Gadd45bΔKup) and in recipients Gadd45b-/- mice with Gadd45b+/+ 
donors (Gadd45bΔhep ). Mice were injected with DEN (100 mg/kg) for 48 hours: 
proliferative, apoptotic process, alongside with IL-6 secretion were assessed. (A)  Top, 
Ki67 immunostaining of livers from Gadd45bΔKup and Gadd45bΔhep  mice, n=3 each group. 
Statistical analysis of Ki67 positive cells with 5 fields of view for each group, data 
represent mean ± S.E.M. (P<0,05). (B) Top, Analysis of Cyclin D1 expression in 
Gadd45bΔKup and Gadd45bΔhep  mice by Western blot after DEN injection. Uninjected WT 
mice were used as a control. GAPDH was used as a loading control. Bottom, 
densitometry analysis of Cyclin D1. Signal is normalized to GAPDH. Values are mean ± 
S.E.M., n=3 mice the treated groups, n=2 in the control group (P<0,01). (C) Blood was 
collected from Gadd45bΔKup and Gadd45bΔhep  mice at the indicated times after DEN 
injection and IL-6 cytokine secretion was analyzed by ELISA, n=3 each group, data are 
mean ± S.E.M. (P<0,05). (D) TUNEL stain of livers from Gadd45bΔKup and Gadd45bΔhep  
mice, n=3 for each group. Statistical analysis of double positive cells with 5 fields of 
view for each group, data are mean ± S.E.M.. 
 
2.1	Gadd45a	is	required	for	DEN-induced	hepatocyte	death	and	compensatory	
proliferation		
 
 Gadd45a shares 55% of homology with Gadd45b but its role in liver homeostasis has not 
been as extensively characterized. Gadd45a is induced by a wide variety of cellular 
stresses, including UV-radiation, X-rays, hypoxia and oncogenic stress and various 
alkylating agents and disruption of its expression was observed in various malignancies 
(Tamura et al, 2012, Alexay et al, 2012). Gadd45a-/- mice show genomic instability, do 
not spontaneously develop tumors, but display increased sensitivity to induced 
carcinogenesis, such as DMBA-induced ovarian tumors confirming its pivotal role in 
maintaining genome integrity (Hollander et al, 1999, 2001). To date however, the role of 
Gadd45a in DEN-induced HCC development remains still unaddressed. We therefore 
examined whether this alkylating agent might affect Gadd45a expression in liver. We 
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found that Gadd45a expression was increased around 20 times after DEN injection (Fig. 
R-7A). To check the biological relevance of this phenomenon, and whether this increase 
plays a role during DEN-induced tumorigenesis, we analyzed the hepatocyte cell death 
and proliferative response in WT and Gadd45a-/- mice 48 hours after DEN injection. The 
lack of Gadd45a in mice caused a decreased hepatocyte cell death after DEN treatment, 
as confirmed by reduced positivity to TUNEL stain and lower Cleaved Caspase 3 signal 
in the Western blot analysis (Fig. R-7B). This decrease in hepatocyte death resulted in a 
decreased compensatory proliferation, as Gadd45a-/- mice showed reduced Ki67 signal 
and reduced expression of Cyclin D1 (Fig. R-7C). Thus, Gadd45a expression is required 
for DEN-induced hepatocyte death and compensatory proliferation. Both processes are 
connected by the release of different cytokines by necrotic cells.  It is established that the 
release of IL-1α  by necrotic hepatocytes upon DEN-stress activates Kupffer cells to 
produce IL-6 which in turn stimulates  hepatocytes to exit the quiescent state and start the 
proliferative phase. We therefore examined the serum levels of inflammatory cytokines in 
WT and Gadd45a-/- mice. Our studies demonstrated that Gadd45a deficiency caused 
decreased levels of IL-1α  and IL-6 after DEN injection. This result might indicate that 
the decreased hepatocyte cell death in Gadd45a-/- mice, upon DEN injury, resulted in a 
reduced production of IL-1α  that in turn stimulates Kupffer cells to release IL-6. 
However, the reduced IL-6 serum level could also be the result of impaired IL-6 
production pathways due to the lack of Gadd45a in Kupffer cells. Together, our data 
indicate that Gadd45a deficiency caused decreased cell death (Fig. R-7B), reduced 
hepatocyte cell proliferation (Fig. R-7C) and decreased levels of inflammatory cytokines 
such as IL-1α  and IL-6 (Fig. R-7D).  
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Figure R-7. Effects of Gadd45a deficiency in hepatocyte cell death and 
compensatory proliferation. A) Gadd45a mRNA expression in the liver of untreated 
WT mice and 5 hours following DEN injection (100 mg/kg) was analyzed by quantitative 
RT-PCR. mRNA was normalized to Gapdh. Values are mean ± S.E.M., n=3 mice in each 
group (P<0,05). (B) Top, TUNEL stain of livers from WT and Gadd45a-/- mice 48 hours 
following 100 mg/kg DEN injection, n=3 each group. Statistical analysis of double 
positive cells with 5 fields of view for each group, data represent mean ± S.E.M. 
(P<0,001). Bottom, Caspase 3 cleavage in the same conditions as the top figure was 
analyzed by Western blot and GAPDH expression was used as a loading control. 
Densitometry analysis of Western blot signal is normalized to GAPDH. Values are 
mean ± S.E.M., n=3 in the treated groups, n=2 in the control group, (P<0,05).  (C) Top, 
Ki67 immunostaining of livers from WT and Gadd45a-/- mice 48 hours following DEN 
injection, n=3 each group. Statistical analysis of Ki67 positive cells with 5 fields of view 
for each group, data are mean ± S.E.M. (P<0,001). Bottom, Expression of Cyclin D1 in 
the same samples was analyzed by Western blot and GAPDH expression was used as a 
loading control. Densitometry analysis of Western blot. Signal is normalized to GAPDH . 
Data represent mean ± S.E.M., n=3 in the treated groups, n=2 in the control group 
(P<0,05).  (D) Blood was collected from both WT and Gadd45a-/- mice at 0 and 5 hours 
after DEN injection. IL-1α  and IL-6 cytokine secretion was analyzed by ELISA, n=3 for 
the treated group, n=2 for the control group. Data represent mean ± S.E.M. (P<0,05).  
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2.2	Gadd45a	promotes	DEN-induced	tumorigenesis		
 
Gadd45a stimulates hepatocytes cell death and proliferation following DEN injection. 
The early induction of these processes is known to have an important impact in the 
development of HCC. To study whether Gadd45a deficient genotype is resistant to DEN-
induced HCC, a cohort of 2 weeks old WT mice and Gadd45a-/- mice was injected with 
DEN (25 mg/kg) and mice were sacrificed after 9 months to assess tumor development. 
While all WT mice develop tumors, nearly 30% of Gadd45a-/- mice are tumor free 9 
months after DEN injection (Fig. R-8A,B). When tumor positive animals in the two 
groups were compared, 45% of WT mice developed more than 10 tumors, in contrast this 
number was just 5% for the Gadd45a-/- mice. Moreover, 60% of Gadd45a-/- mice 
developed less than five tumors, whereas this number represented only 17% for the WT 
mice (Fig. R-8C). The liver to bodyweight ratio was smaller in Gadd45a-/- mice 
compared to WT, suggesting that Gadd45a-/- mice developed tumors with lower cellular 
mass (Fig. R-8D). Remarkably, HCC could be identified 40% of the WT mice and none 
of the Gadd45a-/-. We therefore can say that after 9 months of DEN injection Gadd45a-/- 
mice were HCC free. These evidences point out to a new role for Gadd45a in the 
promotion of DEN-induced tumorigenesis. 
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Figure R-8 Gadd45a promotes liver tumorigenesis. (A) Representative picture of 
DEN-induced liver tumors in WT and Gadd45a-/- mice. 2 weeks old WT (n=13) and 
Gadd45a-/- mice (n=22) were treated with a single injection of DEN (25 mg/kg) and livers 
were harvested after nine months. (B) Percentage of tumor-free mice at nine months. 
Statistically significant differences between WT and Gadd45a-/- mice are indicated (**) 
P<0,01. P value is from a Fisher´s exact test.  (C)  The percentage of tumor-positive mice 
after nine months. (D) The liver/body weight ratio was calculated and expressed as the 
mean percentage  ± S.E.M. Differences between WT and Gadd45a-/- mice were examined 
for statistical significance using the Student´s test, (*) P<0,05. (E) The percentage of HCC 
and adenomas nine months after DEN injection in WT (n=7) and  Gadd45a-/- mice (n=8). 
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2.3	Gadd45a	stimulates	DEN-induced	JNK	phosphorylation	and	NF-κB	activity	
 
As discussed above, ablation of JNK and NF-κB have been linked to a decrease in DEN-
induced tumorigenesis. Moreover, both JNK and NF-κB activity are decreased in 
Gadd45b-/- mice after DEN injection. Given the homology with GADD45B and the 
similar phenotype observed upon DEN injection, we reasoned that Gadd45a might also 
be involved in JNK regulation. Indeed, after 48 hours DEN injection, both JNK 
phosphorylation and NF-κB activity (confirmed by a decrease in IκB〈 phosphorylation) 
were decreased (Fig. R-9). This suggests that Gadd45a and Gadd45b might cooperate in 
a synergistic manner to promote DEN-induced tumorigenesis.  
 
 
 
  
 Figure R-9.  Gadd45a is required for DEN-induced JNK phosphorylation.   WT and 
Gadd45a-/- mice were injected with DEN (100 mg/kg). Phosphorylation of JNK and 
IκBα, along wιth total JNK expression were assessed by Western blot analysis. 
Uninjected WT mice were used as a control. Densitometry analysis of proteins is 
normalized to GAPDH . Data represent mean ± S.E.M., n=3 mice for the treated groups, 
n=2 for the control group, (P<0,05).   
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DISCUSSION 
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Role	of	Gadd45a	and	Gadd45b	in	DEN-induced	HCC	
 
Gadd45 proteins play a key role in the regulation of cell survival, apoptosis, proliferation, 
and maintenance of genomic stability in response to physiological and genotoxic stress, 
including oncogenic stress (Hoffman and Liebermann, 2009). In the current study, we 
evaluated the function of Gadd45b and Gadd45a in liver tumorigenesis, by using the 
DEN model, which represents a well-characterized method of HCC induction.  Our 
results indicate that both Gadd45b and Gadd45a mediate DEN-induced hepatocyte death, 
proliferation and carcinogenesis. 
Over the last decade there are increasing evidences that Gadd45 family can play a role as 
either tumor suppressor or tumor promotor genes depending on the tissue, cell type or 
transforming events. Mice with Gadd45a deletion show genomic instability (Hollander et 
al, 1999), increased sensitivity to carcinogenesis and are more prone to DMBA induced 
ovarian tumors (Hollander et al, 2001). Gadd45a suppresses Ras-driven tumorigenesis in 
breast cancer model by relying on p38-dependent senescence and jnk-dependent 
apoptosis. Furthermore, deletion of Gadd45a in a xeroderma pigmentosum, 
complementation group C (XPC) null model increases tumor malignancy (Hollander et al 
2005) and overexpression of H-ras coupled with Gadd45a knockdown is sufficient to 
transform cells (Bulavin et al, 2003). In addition, Gadd45b-/- mice are more susceptible to 
ionizing radiation, chemical carcinogens, and display an impaired immune response to 
implanted melanoma cells (Ju et al, 2009). Although it has been reported reduced 
expression of Gadd45a and Gadd45b in several tumors and tumor cell lines, mutations in 
these genes are occasional in cancer. Usually, reduced expression of Gadd45a and 
Gadd45b in several types of human cancer correlates with promoter methylation. For 
instance, Gadd45a promoter is hypermethylated in breast cancer when compared with 
normal breast epithelium (Wang et al, 2005). In prostate cancer, Gadd45a promoter is 
hypermethylated and Gadd45a expression is downregulated (Ramachandran et al, 2009). 
Disruption of Gadd45a expression also was found in several hematopoietic malignancies 
(Qiu et al, 2003; Sun et al, 2003; Ying et al, 2005). However, despite their association 
with tumor suppression in many contexts, Gadd45 proteins can also exert tumor-
promotion functions. Gadd45a expression is elevated in several pancreatic ductal 
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adenocarcinoma (PDA) cell lines and loss of expression reduced growth and survival of 
cell lines in culture (Schneider et al, 2006). Gadd45a expression was elevated in 54% of 
human pancreatic ductal carcinomas (Yamasawa et al, 2002) and overexpression of 
Gadd45a and p53 loss of function also contributed to poor prognosis compared with 
patients with low levels of Gadd45a (Yamasawa et al, 2002). In addition, it has been 
reported high levels of Gadd45a  in many cancer cell lines including breast (HS578T), 
lung (NCI-H226), lymphoid (K562), prostate (PC3) and renal (TK10) cell lines 
(Hildesheim and Fornace, 2002). 
Regarding liver carcinogenesis, the role of Gadd45a and Gadd45b has not been studied 
in detail until now. It has been reported that Gadd45b and Gadd45a promoters are both 
methylated in HCC. Downregulation of Gadd45b expression is correlated with 
hypermethylation of the Gadd45b promoter and this is associated with hepatitis C virus 
(HCV)-associated hepatocellular carcinomas (Higgs et al, 2010), suggesting a tumor-
suppressive role for both proteins in HCC.  
Notably, we found that Gadd45b-/- and Gadd45a-/- mice display a substantial decrease in 
tumors number compared to WT mice, nine months after DEN injection. Similarly in 
both groups, 30% of mice are tumor free whereas virtually all WT mice develop tumors. 
Even when the groups of Gadd45b-/- and Gadd45a-/- mice that develop tumors are 
compared, the tumors number is substantially lower than the WT mice. Remarkably, 
when tumors where analyzed histologically, HCC was found in 40% of WT mice, but not 
a single HCC could be found in Gadd45b-/- or Gadd45a-/- mice. The tumors identified in 
both Gadd45a-/- and Gadd45b-/- mice were only adenomas. Therefore, our study provides 
the first direct evidences highlighting a novel role of both Gadd45b and Gadd45a as 
oncogenes during DEN-induced liver stress.  
Given the methylation status and the reduced expression of Gadd45a and Gadd45b in 
human HCC, this result might seem surprising.  Our data indicates that Gadd45 proteins 
have a specific role as oncogenes when liver cancer is induced by an alkylating agent, but 
we can not exclude different roles when liver tumorigenesis is induced by stress factors 
caused by human lifestyle. Using a mouse model of breast carcinogenesis it has been 
found that Gadd45a can act as either tumor promoter or tumor suppressor, depending on 
whether tumors are induced by overexpressing c-MYC or RAS respectively (Tront et al, 
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2006, 2010). Lack of Gadd45a accelerated the onset of RAS-driven mammary tumor 
formation. However, in the mouse mammary tumor virus (MMTV)-Myc mouse model of 
breast carcinogenesis, loss of Gadd45a decelerated the onset of breast tumor formation 
(Tront et al, 2010). 
 
 
 
Role	of	Gadd45b	and	Gadd45a	in	DEN-induced	apoptosis	
	
In liver Gadd45b has been associated with an antiapoptotic function with various sources 
of liver stress. PB produces liver tumors in mice by activating CAR, which in turn 
represses cell death by interacting with GADD45B and repressing MKK7-mediated 
phosphorylation of JNK1 (Yamamoto et al, 2010). Also Gadd45b blocks liver cell death 
after liver stress induced by PH (Papa et al, 2008). In our study, we noticed that 
expression of both Gadd45b and Gadd45a was increased upon DEN treatment. 
Carcinogen induced cell death was significantly decreased in both groups compared to 
WT, as observed by the reduced signal for Cleaved Caspase 3 and reduced positivity to 
TUNEL staining. Also, in the case of Gadd45b, primary hepatocytes show reduced cell 
death after TΝF-α and TGF-β treatment. These findings highlight a new role for 
Gadd45b and Gadd45a as genes exerting a proapoptotic function in DEN-induced 
tumorigenesis. In light of what has been discussed above, the proapoptotic function of 
Gadd45b  might seem surprising. However, it is worth noticing that both PH and PB 
induced liver stress in a DNA-damage independent manner and, therefore, rely on the 
extrinsic apoptotic pathway. DEN instead, induces cell death in a DNA-damage 
dependent fashion. Therefore, the most likely explanation is that Gadd45b  carries a 
proapoptotic or antiapoptotic function according to whether cell death is induced by the 
intrinsic or extrinsic pathway respectively. Interaction with proteins differentially induced 
in one setting or the other might be responsible for the switch.  
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Role	of	Gadd45a	and	Gadd45b	in	DEN-induced	compensatory	proliferation		
 
Whereas the role of Gadd45a in liver proliferation has not been established, various 
evidences point out to Gadd45b as a critical factor, enhancing or suppressing liver 
cellular proliferation in a stimulus-dependent manner. For instance, Gadd45b-/- mice 
display reduced liver proliferation following PH, but a slight increase when liver 
proliferation is induced by treatment with TCPOBOP (Tian et al, 2011). Is important to 
notice that proliferation after PH happens following removal of 3/4 of the liver, whereas 
TCPOBOP is a mitogenic factor which makes hepatocytes enter cell cycle without any 
prior liver insult (Tian, 2011). Hence, the pathways stimulating cellular proliferation in 
one context or in another are very different. Indeed, whereas proliferation after PH is 
JNK dependent (Papa et al 2008), proliferation after TCPOBOP does not depend on JNK. 
In our model, after 48 hours DEN injection, proliferation was reduced in both Gadd45b-/- 
and Gadd45a-/- genotypes confirmed by reduced Ki67 immunostaining and Cyclin D1 
signal. This is consistent with the observed inhibition of DEN induced cell death. To  our 
knowledge, our results show the first evidence that Gadd45a is a positive regulator of 
hepatocyte proliferation in vivo.  Our finding that Gadd45b is required for liver 
proliferation is in line with the same observed role after PH, and is in agreement with the 
phenotype observed in JNK1-/- mice after DEN injection (Sakurai et al, 2006). Indeed, 
JNK1-/- mice display reduced cellular proliferation upon DEN challenge confirming JNK 
as a positive regulator of hepatocyte proliferation.  
 
Role	of	Gadd45a	and	Gadd45b	in	IL-6	production	
 
IL-1α and IL-6 are two paramount cytokines that connect DEN-induced cell death with 
compensatory proliferation. Upon DEN injection, necrotic hepatocytes release IL-1α, 
which in turn activates Kupffer cells to secrete IL-6. IL-6 has been associated with a 
tumor-promoting role in many tumors and elevated IL-6 levels usually indicates poor 
prognosis (Heikkila et al, 2008). IL-6 stimulates hepatocytes to reenter cell cycle. IL-1α 
null receptor and IL6-/- mice show indeed a resistance to DEN-induced tumorigenesis 
(Sakurai et al, 2008; Naugler, 2007). Importantly specific deletion of IL-6 gene in 
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Kupffer cells suppresses the initiation of DEN-induced tumorigenesis and impairs the 
recruitment of cells to the damage site (Kong et al, 2016). Given the lower hepatocyte 
cell death and compensatory proliferation observed in Gadd45b-/- and Gadd45a-/- mice 
after DEN injection, we investigated if these genes play a role in the regulation of these 
cytokines. Whereas IL-1α secretion was decreased in the Gadd45a-/- mice upon DEN 
injection, only a statistical trend of decrease could be observed for Gadd45b-/- null mice. 
We noticed however, that IL-6 production was decreased in both Gadd45b-/- and 
Gadd45a-/-. Also, reduced phosphorylation of STAT3 was observed in Gadd45b-/- mice, 
further confirming decreased IL-6 signaling in these mice. Gadd45b-/- mice showed 
reduced cellular infiltration in terms of neutrophils and macrophages when compared to 
WT mice, a phenotype consistent with the role of IL-6 in promoting immune cell 
infiltration.  
This observation indicates that reduced compensatory proliferation observed in both 
genotypes after DEN injection can be linked to decrease in IL-6 production, constituting 
the first evidence of Gadd45a and Gadd45b promoting IL-6 expression in liver after 
DEN stress.  
 
Role	of	Gadd45b	and	Gadd45a	in	JNK	activation	
 
JNK is a key protein involved in DEN-induced tumor development. Initial studies 
showed that JNK1-/- mice are resistant to DEN-induced tumorigenesis and this resistance 
was associated with reduced expression of Cyclin D1 and the protumorigenic cytokine 
IL-6 (Sakurai et al, 2006). Later studies showed that hepatocyte-specific JNK-/- mice are 
instead more susceptible to DEN-induced HCC. In order to recover the phenotype 
observed in whole body JNK-/- mice, deletion of JNK in myeloid  cells was necessary. 
Mice carrying compound deletion of JNK in hepatocytes and nonparenchymal cells were 
indeed resistant to DEN-induced HCC and display impaired IL-6 secretion (Das et al, 
2011), and mice carrying JNK deletion specifically in myeloid cells were resistant to 
DEN-induced HCC  (Han et al, 2016). These findings imply a crucial role of JNK in 
Kupffer cells-mediated IL-6 production. Given the reduced IL-6 observed in Gadd45a-/- 
and Gadd45b-/- mice upon DEN injection and the conserved interaction of Gadd45 
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proteins with MAP kinase cascade, we examined if JNK is decreased in the liver of 
Gadd45a and Gadd45b deficient animals following DEN injection.  
In our model, we have observed decreased JNK phosphorylation, in both Gadd45b-/- and 
Gadd45a-/- mice 48 hours upon DEN injection when compared to WT mice. We therefore 
examined the phosphorylation of the upstream activators of JNK, MKK7 and MKK4. In 
Gadd45b-/- mice, MKK7 activation did not vary between both genotypes and the WT, 
whereas we could observe no MKK4 activation at 48 hours.  This might imply that 
Gadd45b stimulates JNK phosphorylation through an alternative pathway. Indeed we 
have also found a decrease in the NF-κB signaling in both Gadd45a-/- and Gadd45b-/-, but 
we currently do not know if this difference can be linked to the observed decrease in JNK 
phosphorylation.  Another possibility is that MKK7 and MKK4 may activate JNK at 
earlier time points. The activation of these two kinases at various points after DEN 
injection is currently being investigated in our lab. In addition to the canonical MAPKK 
activation, JNK activation is increased by stress-induced ROS release (Kamata et al, 
2005). ROS indeed can inactivate JNK-specific phosphatases. Therefore, decrease in the 
JNK signaling can be due to a decrease in ROS formation after challenge with DEN 
injection. This however, at least in the Gadd45b-/- animals, appears not to be the case, as 
no differences in ROS accumulation can be observed in WT and Gadd45b-/- mice 
following DEN injection. As mentioned above, JNK deletion in Kupffer cells is 
necessary to downregulate IL-6 production as mice carrying hepatocyte-specific JNK 
deletion increase IL-6 production and develop more HCC (Das et al, 2011). We therefore 
addressed whether expression of Gadd45b specifically in Kupffer cells might restore IL-6 
level and subsequent compensatory proliferation. Thanks to bone marrow transplant, we 
generated mice carrying Gadd45b-specific deletion in monocytes/Kupffer cells 
Gadd45bΔkup or in hepatocytes Gadd45bΔhep. IL-6 production is much higher when 
Gadd45b expression is restored in Kupffer cells compared to hepatocytes, indicating that 
Gadd45b expression in Kupffer cells is necessary to increase IL-6 production. This 
increase in IL-6 expression in turn, is responsible for the increased proliferation observed 
in the livers of Gadd45Δhep animals following DEN injection. At 48 hours, Gadd45bΔkup 
animals showed an amount of Cyclin D1 similar to uninjected WT controls, indicating 
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that compensatory proliferation is minimal or absent. Thus, our model points out to 
Gadd45b as a key regulator of IL-6 expression in Kupffer cells. IL-6 is critical in 
carcinogen mediated liver cancer development, promoting cancer cell proliferation and 
inhibiting the apoptosis of cancer cells by activation of STAT3. Gadd45b-mediated IL-6 
expression in Kupffer cells may be essential for DEN induced carcinogenesis. Our data 
indicates that Gadd45b is an upstream activator of JNK which is required for IL-6 
dependent STAT3 phosphorylation. Our results are consistent with a protumorigenic role 
for Gadd45b in liver cancer by increasing JNK activity in Kupffer cells leading to IL-6 
dependent STAT3 activation. To analyze in more detail how Gadd45b regulate JNK 
activation, immunohistochemical analysis of JNK phosphorylation in Kupffer cells from 
Gadd45bΔkup or Gadd45bΔhep is currently ongoing. 
Concluding	remarks		
In summary our data constitute the first direct evidence of Gadd45a and Gadd45b as 
genes promoting DEN-induced HCC by enhancing DEN-induced cell death and 
compensatory proliferation. After DEN treatment, Gadd45a and Gadd45b induce JNK 
activation in hepatocytes, triggering cell death and promoting IL-1α release. Upon 
binding of IL-1α to its receptor, Gadd45b stimulates IL-6 production in Kupffer cells, 
and we propose that it carries out this function by activating JNK. We are currently 
investigating if Gadd45a realizes a similar function in Kupffer cells by 
generating Gadd45aΔkup and Gadd45aΔhep.Once secreted by Kupffer cells, IL-6 binds to 
its receptor on hepatocytes and promotes hepatocytes proliferation, an essential process 
required for DEN-induced tumorigenesis (Figure D-1). 
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Figure D1. Model illustrating Gadd45b role in promoting compensatory proliferation 
after DEN-Injection by stimulating JNK activation. 
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1) Gadd45b and Gadd45a exert a protumorigenic role during DEN-induced HCC. Lack 
of Gadd45b and Gadd45a suppress the initiation of hepatocellular carcinoma in mice. 
 
2) Gadd45b and Gadd45a promote hepatocyte cell death in response to DEN treatment. 
TUNEL assays and cleaved caspase 3 expression revealed a significant decrease in 
hepatocyte death in livers of  DEN-treated Gadd45b- and Gadd45a-null mice compared 
to WT mice.  
 
3) Gadd45b and Gadd45a are required for efficient compensatory proliferation following 
DEN injection, as the absence of each gene inhibits Cyclin D1 and Ki67 expression. 
 
4) Gadd45b controls DEN-induced hepatocyte proliferation by upregulating IL-6 
expression in Kupffer cells.  
 
5) Gadd45b promotes recruitment of macrophages and neutrophils to the liver after DEN 
injection. 
 
6) Gadd45b and Gadd45a are necessary for DEN-induced JNK activation and IL-6 
signaling. Loss of Gadd45b attenuates both JNK activation in liver and IL-6 production 
by Kupffer cells and this may be crucial to suppress liver cancer development.  
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